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POPULAR SCIENCE SUMMARY OF THE THESIS 
 
The nucleus is the “heart“ of the cell. It contains all the accumulated information about our 
physical appearances, habits and preferences. Every single detail of our body functions is 
written in the form of a genetic code, composed of four elements — four types of 
nucleotides. These nucleotides are aligned in a 2 meter long DNA string. However, this 
extended molecule has to be tightly packed into the extremely small volume provided by 
the nucleus and yet be amenable to differentiate and maintain the numerous cell types of 
our bodies in response to internal and external cues. Each human arises from one single 
cell, the fertilized oocyte, which during prenatal development generates trillions of cells of 
different morphology and function, despite that almost (plasma B cells and T cells the 
exception with rearranged Ig and TCR genes) all of them have exactly the same genetic 
material. The secret to this lies is in the packaging and spatial organisation of genome and 
its dynamic regulation. One could compare it to the piano, which symbolizes the genome, 
while the pianist represents the machinery interpreting the different notes generated by both 
intrinsic and extrinsic signals to define different cell types. A similar phenomena takes 
place in the cell — it is using some part of available genetic material to regulate gene 
expression, and hence its morphology and functions, while storing unnecessary (temporary 
or permanently) genetic units in transcriptionally repressive nuclear sub-compartments  — 
often at the nuclear periphery. Understanding the principles behind this genome 
organisation is crucial not only for understanding how our organism works, but also for 
being able to identify novel therapeutic strategies in case if something goes wrong in the 
cell — during cancer development, for example. 
 
This thesis focuses on chromatin fibres movements within the nuclear architecture and how 
such dynamic processes set the stage for encounters regulating gene expression. By 
exploring “cellular routines” in repositioning certain DNA fragments between active and 
inactive parts of the nucleus, new principles underlying cellular choices of usage of certain 
DNA fragments were uncovered. Again, using the pianist metaphor, one could say that the 
aim of the research is to understand how “the cell” is ”choosing” notes which are going to 
be played in certain moment of its life, and how the notes might be changing in time or in 
response to a changing environment. These aims are highly relevent for our understanding 
of how they can go awry to cause human diseases, such as cancer. By understanding cancer 
architectural complexity, developmental choices and/or responses to outside stimuli, we 
might learn the habits of the “cancer day-scheme” to fight it by cutting off its necessary 






The thesis explores the connection between environmental stimuli and gene expression 
regulated by the spatial changes in genome organization. In Paper I, by applying state of the 
art Circular Chromosome Conformation Capture assay (4C) and Chromatin in situ 
Proximity (ChrISP) techniques, we show that transcriptionally active circadian genes meet 
in space with repressed lamina-associated domains (LADs), and that these interactions are 
under the control of the circadian clock. External time cues thus synchronised circadian 
transcriptional oscillations by repositioning clock-controlled genes from the 
transcriptionally permissive sub-compartment of nuclear interior to the transcriptionally 
repressive nuclear periphery. These processes relied on the rhythmic formation of 
complexes between CTCF and PARP1, two master regulators of the genome, to increase 
the amplitude of circadian gene expression. 
 
In Paper II  we took an advantage of the novel, ultrasensitive Nodewalk technique to 
explore the stochastic nature of MYC interactions with its flanking enhancers. By pushing 
the Nodewalk limits of identification of chromatin interactions in the input material 
corresponding to less than 8 cells, we could show that MYC is likely screening for 
neighbouring interaction partners rather than vice versa. Moreover, we could show that 
MYC does not interact with enhancers, once its transcription had been initiated. These 
findings suggest that enhancer hubs simultaneously interacting with MYC are likely virtual 
consequences of high cell population analyses and that MYC interacts with its enhancers in 
a mutually exclusive manner.  
 
Paper III concentrates on the role of a CTCF binding site within the oncogenic super-
enhancer (OSE) in the regulation of MYC gene gating in colon cancer cells. CRISPR 
induced mutations in the CTCF binding site within the OSE abrogated WNT-dependent 
nuclear export of MYC mRNA, providing genetic evidence to the claim of the OSE-
mediated gating of active MYC alleles to the nuclear pore.This manuscript documents, 
moreover, that the communication between OSE and MYC, as well as their repositioning to 
the nuclear pore, involves PARP1 to indicate a more general role for the CTCF :PARP1 
complex in gene regulation. 
 
In summary, this thesis has uncovered novel principles underlying the roles of stochastic 
chromatin interactions and mobility within the 3D nuclear space to regulate gene 
expression with a focus on circadian transcriptional regulation and the recently discovered 
gene gating phenomenon in humans. These findings contribute to our understanding of 
principles in which the nuclear architecture and genome organisation synergize to induce or 
maintain the properties of the cell. By extrapolation, such findings might form a platform 
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1.1 EPIGENETIC PRINCIPLES 
 
A single human genome can give rise to not only numerous different cell types and 
specialized functions, but also their responses to varying developmental and environmental 
cues. This epigenetic adaptability in the cellular interpretation of genetic information 
depends on the establishment of cell type-specific gene expression patterns. With a mere 
2% of the genome coding for proteins, the remaining 98% of the genome is replete with 
regulatory elements that underlie context-specific gene activity(1). Chromatin adaptations 
implemented by the epigenetic machinery as well as its 3D mobility are key factors in the 
induction and subsequent stable propagation of gene expression pattern without altering the 
underlying DNA sequence(2). Moreover, the chromatin fibre is an essential platform on 
which transcription factors (TF), singling pathways and other chromatin modifications 
converge and in some instances collaborate in response to environmental stimuli(1). Thus, 
chromatin states maintain flexible features in response to the appropriate cues and 
conditions and yet are stable enough to ensure the propagation of robust phenotypes during 
development. Consequently, the loss of this robustness increases the potential for disease 
development(1,3–5). However, very little is known about the mechanisms which govern the 
transitions between normal and pathological epigenetic plasticity. It has been proposed that 
the compartmentalization of active and inactive domains, co-existence of different 
epigenetic marks as well as interactions between different chromatin loci or regulatory 
elements like promoters and enhancers underlie how chromatin states respond to 




1.1.1 The primary chromatin fiber 
 
The 6 billion bases of coding and non-coding DNA of the diploid genome are wrapped 
around approximately 30 million nucleosomes to form chromatin, which is the 
physiological and structural form of human genetic information(1,2). Nucleosomes are 





linker region of ca 20-40 bp to define the ‘primary structure’ of chromatin fibres. This 
simplified picture is, however, compounded by the ever-increasing number of histone 
variants as well as of post-translational histone modifications (PTMs) and DNA 
modifications(8), to generate an almost astronomical number of theoretically possible 
variations in the chromatin primary structure. The PTMs play important roles in 
establishing equilibriums between different structural states, including the regulation of the 
chromatin compaction as well as the interactions between nucleosomes and non-histone 
proteins. Among many distinct histone PTMs, acetylation of lysine residues and 
methylation of arginine residues are best known. Thus, acetylation of lysine neutralizes the 
positive charge of the amino acid and is often associated with chromatin decompaction and 
vice versa, whereas arginine methylation plays important roles in the regulation of gene 
expression(6,9). These and other PTMs decorate not only the chromatin of gene bodies, but 
also regulatory elements, such as enhancers. Regular enhancers are typically defined as 
short (~100–1000 bp) noncoding DNA sequences, composed of concentrated clusters of 
transcription factor (TF) recognition motifs. Such complexes tend to bend the DNA to 
generate so-called DNase I hyper-sensitive sites demarcating such regions(10–13). The type 
of combinatorial PTMs associated with regulatory regions defines their functions. For 
example, active enhancers are marked with H3K4me1, H3K27ac, H3K122ac and absent or 
low levels of H3K27me3 and H2K9me2/3 marks. Conversely, enhancers which are poised 
to become active enhancers are demarcated with both active and repressive marks, such as 
H3K4me1 and H3K27me3(6,14,15). This picture is complicated, however, by the 
demonstrations that some of the enhancer regions can be devoid of the typical enhancer-
specific chromatin marks(16,17). It has been estimated that each cell type can have 
anything from 10,000 to 150,000 enhancers with an accumulated number exceeding 1 
million enhancers active in all human cells(11,18,19). Accordingly, enhancers are key 
regulatory elements controlling tissue-specific transcription programs and thus essential for 
the robust maintenance of a diverse range of phenotypes(20). More recently, a new class of 
enhancers, the so-called super-enhancers (SE), has been identified. Such regions are often 
found near genes that control cell states and have cell type-specific functions in response to 
a diverse range of signaling pathways(11,18,20). SEs are defined not only by the usual 
enhancer marks, such as H3K4me1, H3K27ac, master TFs, p300, but also by the prominent 
presence of the Mediator complex (Med1)(10,11). A schematic representation of the loop 





Figure 1. In a comparison to typical enhancers (TE), SE typically spreads from 10 kb to 
over several hundreds of kb (while the median size of TEs ranges from 1 kb to 4 kb), often 
contain more than one separate region that is bound by multiple TFs (such as OCT4, SOX2 
and NANOG in Embryonic Stem Cells), drive targeted gene transcription with a high 
precision potentially related to the higher expression of enhancer RNAs (eRNAs) than 
typical enhancers. Accordingly, the number of SEs in each cell type is fewer by one to two 











Fig.1 Schematic loop formation between promoter and super-enhancer Super-enhancers 
are enriched in histones modifications (H3K4me1 and/or H3K27ac) as well as 
transcription factors, p300 and the Mediator complex. CTCF can bind to chromatin to 
establish domain boundaries, enhancers and promoters. Bi-directionally transcribed 
eRNAs play stabilizing roles in loop formation between promoter and super-enhancer by 






1.1.2 3D chromatin interactions 
 
The enhancer needs to physically interact with the promoter of its target gene to initiate its 
transcription. This is an essential step to ensure that the correct set of genes are turned on at 
the correct time during a developmental window(24). Physical enhancer-promoter contacts 
generally involve collaboration between the Mediator complex at the enhancer and 
promoters which usually are marked with the H3K4me3 modification. The resulting 
chromatin loop involves the cohesin complex that promotes the search for promoters with 
active marks by a loop extrusion principle(17,25,26). The formation of enhancer-gene loops 
can be further stabilized by enhancer RNAs (eRNAs), which constitute links between 
enhancers and their target genes(20,27). The CTCF (CCCTC-binding factor) is another 
important factor, also for SEs, by being able to physically link distal regions to form 
chromatin loops with a median size ca. 200kb in convergent orientations. The loss of this 
feature, which promotes highly specific and precise SE-promoter interactions, affects loop 
domains and transcriptional patterns(21,27–30). Moreover, the CTCF binding site can 
provide a structural hierarchy necessary for the function of SEs (by mediating and/or 
facilitating long-range chromatin interactions) (27,31). However, very little is known about 
the mechanisms underlying the regulation of such chromatin loops – a situation further 
compounded by the fact that only 7% of distal regulatory elements control the most 
proximal promoters with enhancer regions located anywhere from 1kb to tens of Mbs away 
from their target promoters(6,17,25). Moreover, one enhancer can contact more than one 
promoter(25). It is also important to note that interactions between promoters and enhancers 
might be established without leading to overt transcriptional initiation. Indeed, for the large 
subunit of the RNA polymerase complex to trigger transcription it must acquire a serine 2 
phosphorylation mark at its large subunit(17,24). 
Apart from promoter-enhancer interactions, chromatin interactions can involve different 
types of regulatory elements like promoter-promoter, enhancer-enhancer or insulator-
insulator loops(24). The chromatin insulator is a sequence element of DNA that blocks 
enhancer-promoter interactions in a position-dependent manner to potentially contribute to 
the spatial arrangement of chromosomes in the nucleus(30,32). However, their ability to 
antagonize  enhancer-gene interactions is position-dependent - the promoter thus remains 
capable of being activated by other enhancers and the enhancer can activate other 





sensitive, CTCF-dependent chromatin insulator and has been shown to physically interact 
with a differently methylated region (DMR) with a silencer function at the maternally 
inherited Igf2 allele(33,34). The H19 ICR region is inherited unmethylated from the 
maternal germline and methylated from the paternal germline to direct parent of origin-
specific expression of the proximal H19 and the more distal Igf2 alleles. Since only the 
unmethylated H19 ICR is able to bind CTCF, only the maternal Igf2 allele is insulated from 
downstream enhancers. This feature requires the ability of the CTCF-H19 ICR complex to 
form chromatin loops(33–38). Conversely, while the paternally methylated H19 ICR allele 
is unable to prevent activation of Igf2, it silences the H19 gene. 
 
1.2 NUCLEAR ORGANIZATION 
 
1.2.1 Spatial separation between active and inactive chromatin states 
 
As discussed above, a fundamental property of the genome is its spatial organization at 
several, hierarchical levels in cell nucleus. In interphase nuclei, individual chromosomes 
occupies a limited space called chromosome territories, which are approximately 2-4 μm in 
diameter(7,39). Despite cell type-specific differences in the localization of individual 
chromosome territories in individual cells, larger (and gene-poor) chromosomes tend to 
locate close to the nuclear periphery while smaller and more gene-rich chromosomes 
inhabit a more central position(40). One of the most striking features of the chromosomal 
organization is thus the global spatial separation of active and inactive chromatin referred to 
as A (active) and B (inactive) compartments, which are further divided into sub-
compartments with distinctive chromatin states, association with nuclear landmarks and 
replication timing(40–42). Within nuclear sub-compartments chromatin is organized into 
topologically-associated domains (TADs) - areas of highly interacting chromatin separated 
from each other by, for example, CTCF boundaries demarcating the TADs(29,40,43). The 
constraining of chromatin movements between TADs likely restricts contacts to involve 
only neighboring enhancers and promoters(44). TADs can be either A-type (with open, 
gene-rich chromatin) or B-type (gene-poor, closed chromatin)(45). Lamina-associated 
domains (LADs) are distinct regions of the genome interacting with nuclear lamins (a thin 





10Mb, are AT-rich and contain H3K9me2 and H3K27me3 marks with poor representation 
of H3K36me3(39,45) to constitute 35-40% of the mammalian genome(29,45,46). Similarly 
to TAD borders, LAD borders are enriched in CTCF binding sites(45) and approximately 
9% of LAD borders contain CTCF within 10kb of the boundary(47). Furthermore, LADs 
are represented by cell type-specific variants (facultative, fLADs) or cell type-invariant 
(constitutive, cLADs) LADs(48). These types of LADs differ from each other in gene 
density and conservation between mouse and human(48). Interestingly LADs overlap to a 
high degree with Large Organized Chromatin Lysine Modifications (LOCKs), which are 
regions enriched in the H3K9me2 mark and highly dynamic throughout the differentiation 
of murine embryonic stem cells (mESC)(45,48). Genes localized within LOCKs are 
typically silenced and comprise 31% of the genome of differentiated ES cells, but less than 
5% in undifferentiated cells(49). Interestingly both LADs and LOCKs might play an 
important role in the regulation of chromatin movements.  
 
1.2.2 Chromatin movements 
 
Although the distribution of the chromosome territories within the nucleus to a high degree 
depends on their size and gene-richness, their preferred position is not absolute(50). This 
also translates to the kind and dynamics of chromatin fiber interactions and distinct loci of 
particular chromosomes manifest different features in terms of mobility and search for 
interacting partners(51). Whereas most chromatin interactions take place within the 
chromosome territory, genes and regulatory regions can also interact in trans with inter-
chromosomal interactions occurring preferably at the edge of chromosome territories(7). 
However, particular loci can also loop into the CT of another chromosome or multiple loci 
can loop out of their CTs(7,38). The mobility of distinct loci depends on their position 
within nuclear sub-compartments with genes associated with the nuclear periphery or the 
nucleolus exhibiting significantly lower mobility in comparison to genes within the 
nucleoplasm(52). Such features may underlie long-range chromatin interactions that have 
been implicated in the epigenetic regulation of gene expression(51).  
Experiments with molecular tethering to the nuclear periphery using an inducible system 





reversibly repress the activity of these genes in human cells(53). Although not a universal 
feature, the tethering of some of genomic loci to the periphery is thus generally promoting 
silencing of gene activity(54). Conversely, it is generally considered that the mobility of 
active chromatin to the site of mRNA export, the nuclear pore, might increase expression 
efficiency(55). The so-called ‘gene gating’ phenomena thus states that certain loci can be 
juxtaposed to the nuclear pore and facilitate rapid nuclear export of processed mRNAs. In 
one such example, it was shown that an oncogenic super-enhancer mediated the 
repositioning of active MYC alleles to nuclear pores, which enabled MYC transcripts to 
escape the more rapid degradation pathway in the nucleus than in the cytoplasm in colon 
cancer cells(55–57). Of note, Paper III provide genetic evidence in support of this scenario 
by showing that a single CTCF binding site within the oncogenic super-enhancer 
coordinates the WNT-regulated gating of MYC to the nuclear pores. In contrast to short-
range interactions, global mobility of chromatin might depend on the actin/myosin system 
to seemingly produce active and directed movements(58). The specificity of the 
repositioning of certain loci to the nuclear periphery is likely dependent on a combination 
of DNA sequence, trans-acting factors, PTMs and lncRNA(6,59).   
 
1.2.3 Chromatin hubs vs stochastic movements 
 
The nuclear architecture is dynamic in nature and yet stably maintained(7). This may relate 
to that the nucleus is considered to be built mainly by self-organizing principles(51,60). 
Such a dynamic environment displays a high level of stochastic collisions between 
chromatin fibers. Although gene expression itself is a fundamentally stochastic process, 
transient chromatin fibre interactions don’t necessarily imply any regulatory function(7,61). 
Nonetheless, enhancer interactions both in cis and trans as well as the establishment of the 
so-called transcription factories provide well documented examples for the meta-stable 
character of such functional chromatin networks(17,62,63). However, the frequency of 
spatial meetings between two interacting genomic regions is not universal for all cells in a 
cell population(51). Even though chromatin-fiber interactions might display a high level of 
noise to appear largely non-functional, they might increase the potential for a functional 
outcome to contribute to cellular plasticity as well as establishing/maintaining stochastic 





1.2.4 Contribution of CTCF and PARP1 to chromatin interactions and mobility 
 
As noted above, CTCF plays an important role in the formation of chromatin loops. CTCF 
is an evolutionary conserved 11-zinc-finger protein with ability to bind various DNA motifs 
and different regulatory proteins(66–68). Its ability to interact with DNA, proteins as well 
as RNA is a consequence of its domain organization – the central zinc-finger domain 
allows CTCF to bind DNA with the use of different zinc-fingers combinations, whereas 
binding to its protein partners is mediated via interactions with any part of the entire 
protein, i.e. its central zinc finger domain or the N- and C-terminal parts. For example, N-
terminal region has the ability to bind PARP1 protein, as described later in the text, while 
the unstructured C-terminal region can bind RNA(66,67). The complexity of the CTCF 
structure translates into the various significant roles CTCF plays in regulation of cellular 
processes and development.  
 
CTCF was initially discovered as a transcriptional repressor of chicken c-myc gene(69) and 
its important function as an insulator in the regulation of Igf2/H19 imprinting has been well 
studied(35,70–72). Subsequent research showed that CTCF binds to 40,000-80,000 sites 
genome wide in mouse and human ESCs to play role in alternative splicing, DNA repair, 
recombination and mediation of enhancer-promoter interactions(17,66,73–75). Many, but 
not all, of CTCF binding sites are co-occupied by the cohesin complex, which physically 
interacts with CTCF as a biochemically stable complex. Together they shape chromatin 
architecture, although CTCF and the cohesin complex differ in the dynamics of chromatin 
binding and mechanism of contribution to the chromatin organization(76–81). CTCF, 
which has been characterized as a master weaver of the genome(67), also binds to a wide 
range of factors including PARP1. Although PARP1 is mostly known for its role in DNA-
damage response, it has been implicated in epigenetic modifications of both histones and 
DNA as well as maintaining the integrity of constitutive and facultative 
heterochromatin(82–84). Many of these functions are in partnership with CTCF, as 
witnessed by the PARP1-mediated poly(ADP-ribosyl)ation of its N-terminal region 
(82,85). Dynamic PARylation of CTCF in response to cellular signals or environmental 
cues thus plays an important role in CTCF-dependent chromatin insulation and loop 





1.2.5 Technologies exploring 3D chromatin structures 
 
The mapping of the 3D structure of the genome has been possible thanks to technological 
achievements represented by two main approaches: In situ techniques, such as proximity 
ligation and 3D DNA FISH(89) and chromosome conformation capture (3C) and derived 
“C” techniques(90). The “C” family of techniques focuses on local and/or genome wide 
DNA-DNA contacts and involves restriction digestion of formaldehyde-crosslinked 
chromatin followed by intra-molecular ligation to identify proximities between distal 
regions (Fig.2). In the original 3C technique, this was performed by PCR, while later 
versions of the method rely primarily on high throughput DNA sequencing(91,92). The 
parental 3C technique has been extensively used to demonstrate interactions, such as 
formation of chromatin loops between two genomic loci(91). However, the drawback of 
this technology is that it is based on educated guesses that two particular regions might 
interact. To overcome this biased limitation, Circular 3C (4C) in combination with high 
throughput sequencing was innovated(38). Strategic placing of the primers within the bait 
and formation of circular DNA between bait and interacting sequences allowed the 
identification of unknown intra- and inter-chromosomal interactions of a bait(93,94). Next, 
the chromosome conformation capture carbon copy (5C) allowed obtaining information on 
contacts between multiple genomic loci(95). This was possible by introducing a step where 
3C products were incubated with a mix of specific oligos which annealed exactly at one of 
the restriction sites covering an entire genomic region of interest(91). However, the “many-
to-many” 5C strategy was subsequently replaced by an “all-to-all” approach represented by 
the Hi-C technique. The introduction of biotin-labeled nucleotides for filling restriction 
“sticky-ends” (followed by “blunt-ends” ligation) allowed the selection of ligation junctions 
by biotin pull-down(89,96). Although the Hi-C technique has been very useful to study 
genome wide TAD structures, it is less ideal for the examination of individual loci 
interaction pattern due to low resolution and reduced statistical power(91). Moreover, 
similarly to almost all of the other 3C-based methods, Hi-C analyses are mostly performed 
on the cell-population level with low sensitivity to blur the dynamics of chromatin 
encounters. Thus, Hi-C maps are unable to discriminate between stable 3D contacts present 
in all cells and an average of stochastic contacts which can differ between particular cells of 
a cell population(97). The single-cell Hi-C (which introduces an in-nucleus ligation step) 
helped to overcome the problem of the use of cell population, but the technique still suffers 





amplification steps – a feature shared by almost all “C” techniques, is likely to introduce a 
bias. This limitation is resolved by including a linear RNA amplification step in the newly 























Another common limitation of all the ”C” family techniques is that they do not with few 
exceptions (Paper I) provide robust information as to where in the nuclear space the 
interactions take place and their frequency of interactions. This generally acknowledged 
drawback usually requires validation of identified interactions by microscopy assays, such 
as 3D fluorescence in situ hybridization (3D-FISH). Whereas the power of this technique 
lies in that it represents a single-cell analysis of gene positioning to provide information of 
chromatin dynamics in relation to the nuclear architecture, it is limited by the resolution of 
the fluorophores of choice(89). To quantitatively detect chromatin proximities in single 
cells with an optimal resolution, chromatin in situ proximity (ChrISP) assay is a method of 
choice(99). This technology detects proximities between two different antibodies (against 
labeled probes specific to target DNA sequences, or between a DNA sequence and any 
other epitope represented by a protein, for example) within 160Å of each other and allows 
the spatial visualization of chromatin interactions or higher order chromatin confirmations 
in single cells in relation to structural hallmarks(100).  
 
 
1.2.6 The Nodewalk technique 
 
The Nodewalk method is a member of “C” family techniques which rely on the ligation of 
digested DNA to generate covalently linked intra-molecular chromatin complexes. 
However, the DNA tagmentation by transposase allows both further fragmentation of 
ligated DNA and the incorporation of suitable, tailed primer sequences in Nodewalk, 
including the promoter for T7 RNA polymerase, followed by only 5-7 amplification cycles. 
This step avoids amplification biases and allows the generation of a template for the in vitro 
linear, production of large amounts of RNA from very small amount of input material. 
Following the selection of bait, specific primers positioned close to a restriction enzyme 
site can be used to prime cDNA synthesis and subsequent high throughput sequencing. 
Nodewalk thus combines high resolution with high sensitivity improving it >10,000-fold in 
comparison to other “many-to-all” techniques. This in turn allowed the reproducible 
identification of chromatin interactions in input material corresponding to less than 8 





underlying the discovery of the gating of the active MYC gene to the nuclear pore in human 
colon cancer cells(56). 
 
1.3 THE 4TH DIMENSION OF THE REGULATION OF NUCLEAR FUNCTIONS 
- INTRODUCTION TO THE CIRCADIAN RHYTHM. 
 
Many cellular processes, including chromatin movements or chromatin fiber interactions, 
exhibit periodic behavior. These time-dependent events are often regulated by the circadian 
clock machinery that likely has evolved to maximize organismal fitness in response to 
changing external cues. The circadian clock is a highly conserved system that enables 
organisms to adjust to daily changes in the environment, such as food availability and 
night-day cycles(102). It controls a variety of physiological processes like hormone 
secretion, feeding behavior or sleep-wake cycles. Almost all eukaryotic organisms manifest 
behavioral, physiological and metabolic oscillations, with a period of ca 24 hours. 
Circadian rhythms display unique properties – although endogenous free-running periods of 
approximately 24h, the phase of the rhythm can be entrained or re-set by external time cues. 
Moreover, the periodicity of circadian rhythm is stable across a wide range of temperatures 
(termed temperature compensations)(103). The mammalian timing system exhibits a 
hierarchical architecture with the master pacemaker located in the suprachiasmatic nucleus 
(SCN). This controls the phase of oscillations at both the tissue and cellular levels(104) by 
providing an output to peripheral tissues (peripheral clocks) following its synchronization 
by external time cues, such as light. Peripheral clocks oscillate autonomously and can be 
entrained also by food intake(104,105). At the cellular level, the molecular clock machinery 









































In mammals, the positive limb of the core TTFL feedback loop consists of two 
transcriptional activators: the circadian locomotor output cycles kaput (CLOCK) and brain 
and muscle ARNT-like protein 1 (BMAL1) proteins. They form a heterodimer to promote 
the expression of the negative elements (PERIOD (PER) and CRYPTOCHROME (CRY) 
homologs). Following a time delay, dimerized complex between PER and CRY translocate 
to the nucleus where they inhibit the action of CLOCK/BMAL1 
Fig. 3 Schematic representation of mammalian core circadian feedback loops. The 
positive feedback loop (CLOCK/BMAL1) regulates the transcription of negative 
feedback loop components – PER and CRY. PER and CRY proteins enter the nucleus to 
suppress the transcriptional activity of the CLOCK/BMAL1 complexes. The machinery 





complexes(102,103,106,107). The core TTFL is, moreover, coupled to other sub-loops 
which contribute to the functions of the circadian clock. One of these sub-loops comprises 
transcription factors reverse erythroblastosis virus-α (Rev-erbα) and retinoic acid receptor-
related orphan receptor-α (RORα) which bind to RORE in the BMAL1 promoter to either 
activate (RORα) or repress (Rev-erbα) BMAL1 transcription(102,103,107,108). The 
principles of mammalian core circadian feedback loops are schematically shown in Figure 
3. The core clock machinery is connected to many cellular pathways and has additional 




1.3.1 The entrainment of circadian rhythm 
 
As mentioned in chapter 1.3, the synchronization of the clock to 24h oscillations requires 
entrainment by external timing cues, also called “synchronizers”, “zeitgebers” or 
“entraining agents”(107). Circadian rhythm synchronization can be obtained by variety of 
factors, which relate to the architectural organization of the clock machinery. Among them, 
light and food are well studied examples of external cues that regulate the activity of the 
clock components. Following the recognition of light at the retina, the signal reaches the 
SCN via the retino-hypothalamic tract(109). This “photic entrainment” indirectly regulates 
light-insensitive peripheral clocks by both humoral and non-humoral pathways(107,110). 
Food composition and their timing of ingestion, on the other hand, cause periodic changes 
in the availability of circulating macronutrients, which can reset the circadian clocks 
specifically in peripheral tissues(103,107). Temporal food restriction can induce circadian 
rhythmicity of locomotor behavior even in animals with SCN lesions(111). At the 
molecular level, the feeding process increases blood glucose levels, which can both 
downregulate the expression of PER1 and PER2, and indirectly regulate CRY 
stability(112,113). The complexity of the clock machinery is further exemplified by the 
observation that the CLOCK/BMAL1 binding to DNA can be affected by food restriction-
dependent alternations in the cellular redox state(107). Apart from food and light, 
synchronization of the phase of the circadian rhythm can be obtained by action of other 
synchronizers, such as arousal stimuli, which include social interactions, exercise, stress or 





rhythms is their temperature compensation (the period length is maintained in a wide range 
of physiological temperatures), peripheral cells and tissues can be synchronized by 
temperature fluctuations(107). Not only in vivo models but also in vitro cell cultures or 
explants can be synchronized in their circadian rhythms, and many factors can function as 
zeitgebers. It was shown that serum shock, for example, can affect the molecular circadian 
clock, and various factors in the blood, such as glucose, calcium, EGF, PGE2 or 1α,25-
dihydroxyvitamin D3, can affect rhythmic oscillations(107,115). Finally, chemical 
compounds, such as dexametasone (an artificial glucocorticoid) or forskolin (which acts 




1.3.2 The role of circadian rhythm 
 
Circadian rhythms (CR) play important roles at both the organismal and cellular levels. 
Their existence provide organisms with selective behavioral advantages, allowing for 
instance the anticipation of daily food availability and predator avoidance(118). Moreover, 
CR allow the physiological adaptation of the organisms to food intake, metabolism and 
detoxification, and the circadian clock of plants prepares them to kick-start photosynthesis 
in the presence of appearing light energy by ensuring the production of photo-system I and 
II components already before the sunrise(118–120). Additionally, temporal separation of 
chemically incompatible cellular processes acts in favor for the organisms. For example, 
simultaneous photosynthesis and nitrogen fixation in cyanobacteria would cause inefficient 
nitrogen fixation due to the poisoning of the nitrogenase by oxygen generated during 
photosynthesis(121). It has also been suggested that the circadian clock underlies the 
heterogeneity in stem cells populations, to promote developmental potential(122). Studies 
with mouse models showed, moreover, that epidermal stem cells in hair-follicle bulge 
coexisted as two subpopulations, which differentially expressed core components of the 
clock machinery to prevent simultaneous expression of genes responsible for stem cell 
dormancy, proliferation or differentiation, such as TGFß and WNT pathway members(123–
125). The DNA damage response is yet another biological process affected by the circadian 
rhythm – the ability to repair UV irradiation-induced DNA damages were higher in the late 





the fact that a majority of circadian genes are not only expressed in a tissue-specific 
manner, but also that different circadian transcripts might accumulate with different phases 
in different cell populations within a tissue. This heterogeneity is likely the sum of 
differences both in the spatial distribution of environmental cues and the ability of the cells 
to respond to these cues(119). Accordingly, the disruption of circadian rhythms by 
unhealthy lifestyle or shift working, as well as polymorphisms/mutations in the clock genes 




1.3.3 Circadian organization of the epigenome 
 
Many studies have made the link between distinct epigenetic regulatory layers and the 
regulation of circadian transcription. One of the earliest reports showed that the 
phosphorylation of H3 at Serine 10 is light-dependent in SCN neurons(128). Subsequent 
studies reinforced this observation by showing that epigenetic modifications, such as DNA 
methylation and PTMs of histones, play roles in rhythmic transcription. For example, both 
the activating H3K4me3/H3K9ac and the repressive H3K9me3 marks exhibits circadian 
rhythmicity at regulatory regions(129–132). Consequently, the recruitment of PolII to 
promoters of circadian genes as well as its regulation at the elongation step display 
circadian-depended variations(131,133). To sustain circadian dynamics of the epigenome, 
the molecular clock collaborates with many epigenetic modifiers. These include mixed 
lineage leukaemia 1 (MLL1, interacting with CLOCK/BMAL1), nucleosome remodeling 
deacetylase (NuRD, which interacts with and assists the PER complex) and the Polycomb 
group enzyme KMT6/EZH2, which co-precipitates with CLOCK/BMAL1(131–134). 
However, the circadian clock also influences the nuclear architecture and the topology of 
the genome. One of the first indications of this effect were shown in the studies of 
Chlamydomonas reinhardtii revealing diurnal oscillations of DNA supercoiling in the 
chloroplasts(135). Similarly, temporal changes in the organization of the albumin D 
element-binding protein (Dbp) circadian gene and its 3D chromatin fibre interactome could 
be observed in the mouse. Thus, rhythmic changes in the local chromatin condensation 
conferred oscillating transcription of genes included in the Dbp circadian interactome in 





1.3.4 The roles of CTCF and PARP1 in the circadian cycle 
 
Since the chromatin fibre serves as a platform for the integration and propagation of many 
signaling and metabolic pathways, many cellular factors, which are not directly categorized 
as part of the core clock machinery, might be affected by or influenced by the circadian 
rhythm. This is exemplified by CTCF and PARP1, which influence chromatin interactions 
and mobility, as described in detail in chapter 1.2.4. Thus, PARP1 can influence food 
uptake since its loss of function correlates with diet-induced obesity(138,139). Moreover, 
Asher et al. showed that ADP-ribosylation of PARP1 oscillates in a rhythmic manner in 
synchrony with feeding-fasting cycles in the mouse liver(140,141). These findings provide 
an important link between circadian rhythms and metabolism, and have inspired the 
formulation of a molecular model. This posits that at the beginning of the light phase 
PARP1 binds to and poly(ADP-ribosyl)ates CLOCK. The loss of PARP1 would therefore 
cause a phase-shift in the interactions between CLOCK/BMAL1 and PER/CRY complexes. 
In line with this reasoning, mice lacking a functional Parp1 gene displayed impaired food 
entrainment of peripheral circadian clocks(140,141). CTCF, one of the partners of PARP1, 
prominently binds to CLOCK/BMAL1 enhancers implying that these factors join forces to 
facilitate long-range chromatin interactions between CLOCK/BMAL1 enhancers and their 
target genes(142). But their ability to join forces to effectuate the circadian rhythm does not 
end there. 
 
    
1.3.5 Transcriptional activation and repression directed by chromatin movements 
 
As circadian transcription takes place in the context of the 3D nucleus, mechanisms 
allowing genome wide cyclic chromatin transitions must relate to the structural hallmarks 
of the nucleus(129). Paper I demonstrated that such events include a collaboration between 
PARP1 and CTCF. In short, this novel finding showed that circadian interactions between 
CTCF and PARP1 were driving the rhythmic recruitment of a subset of genomic loci to the 
repressive nuclear periphery(143). Subsequently, another study implicated that CTCF and 
PARP1 influenced the repositioning of the Arntl2 mouse gene in breast cancer cells(144). 
Thus, Ha et al. showed that the presence of SNP at the promoter of this gene affected its 





the recruitment/release of the Arntl2 gene to/from the nuclear envelope, thereby altering the 
timing of Arntl2 expression(144). Correlation between chromatin mobility and changes in 
transcriptional state has been observed also in Arabidopsis thaliana(145). Feng et al. 
showed that the chlorophyll a/b-binding proteins (CAB) locus migrates from the nuclear 
interior to the nuclear periphery during its transcriptional activation, and that this relocation 
was triggered by light. Similar light-induced repositioning during transcriptional activation 
has been documented for the Rubisco small subunit (RBCS), plastocyanin (PC) and 
genomes uncoupled 5 (GUN5) loci(145).  
 
1.3.6 Connection between enhancers and circadian chromatin movements  
 
Circadian dynamics altering spatial gene regulation and transcriptional feedback events 
likely reflect rhythmic enhancer-promoter communications(146). This supposition was 
borne out in two parallel studies from Mermet et al. and Kim et al., in which both groups 
highlighted the connections between circadian rhythms and 3D genome folding(147,148). 
Mermet et al. used the 4C technology to demonstrate that clock-controlled promoter-
enhancer interactions act as regulatory layers underlying circadian transcription in mouse 
liver and kidney. Accordingly, the deletion of intronic enhancer elements in Cry1 or Bmal1 
influenced circadian rhythmicity(148). Similarly, Kim et al. showed that circadian gene 
expression is in mouse liver controlled by rhythmic interactions between promoter and 
enhancer elements, and that Rev-erbα contributed to rhythmic gene expression by 
antagonizing the formation of functional loops between target gene promoters and Rev-
erbα-regulated enhancer(147,149). It remains to be seen, however, how such rhythmic 
enhancer-promoter interactions relate to their position within the nuclear architecture and 
the potential rhythmic mobility of the involved regions between transcriptionally 
permissive and repressive nuclear environments. This question is in the focus of Paper III, 
showing that the gating of MYC to nuclear pores required coordination of enhancer-
promoter interactions with the recruitment of this complex to nuclear pores by CTCF and 
PARP1. As the MYC gene is expressed in a circadian manner in many different cell 
types(150), this finding raises the question whether the rhythmic repositioning of circadian 
genes to the nuclear periphery might initially involve their anchoring to nuclear pores to 





transfer to the repressive compartments surrounding the nuclear pores to attenuate their 








In summary, accumulated findings from several decades of intense research have 
broadened our understanding of spatial genome organization and its role in the regulation of 
many cellular processes, such as gene transcription. The discoveries of the functional 
divisions of transcriptionally permissive and transcriptionally repressive compartments 
reinforces the view that the genome is not randomly compacted in the nucleus, but that its 
compaction is highly controlled to maintain cellular plasticity, ie to provide a preparedness 
responding to environmental cues. Chromatin fibre interactions and movements emerge as 
crucial factors underlying the regulation of cellular identities. Crucially, the cell phenotypes 
must remain robust in their responses to the outside stimuli. These scientific advances have 
been made possible due to the development of highly sensitive technologies allowing the 
examination nuclear processes with an increasing precision.  
 
Recently, the Nobel Prize in Physiology and Medicine was awarded to Jeffrey C. Hall, 
Michael Rosbash and Michael W. Young for their discoveries of molecular mechanisms 
regulating circadian rhythms. These and many other findings point towards to the future 
need to emphasize novel 4D research approaches, which focus on how the time plays a 
crucial role in regulating chromatin transitions within the 3D nuclear architecture in 
response to Zeitgebers. However, the examination of time-limited processes still represents 
a considerable technological challenge, and only the development of more sensitive 
methodology that preserves spatial genome organization will allow scientists to answer 
remaining key questions, such as: what are the principles behind regulated chromatin 









2 RESEARCH AIMS 
 
The overall aim of this thesis was to explore the connection between environmental signals 
and 3D genome organization underlying the regulation of gene expression. To this end, three 
independent studies were designed with the following questions: 
 
1. How do external cues regulate gene expression in the compartmentalized nuclear 
architecture? Specifically, does the synchronization of the circadian rhythm regulate 
the movement of circadian chromatin loci between repressive and permissive 
nuclear compartments, accompanied by transcriptional changes? What is the 
underlying molecular mechanism? 
2. What is the relationship between stochastic transcriptional bursts and dynamic 3D 
chromatin states? Specifically, how does MYC communicate with its enhancers in 
relation to its transcriptional activity? 
3. What are the molecular mechanisms that coordinate enhancer-promoter 
communications and the localization of enhancer-promoter interactions within the 
3D nuclear architecture? Specifically, does CTCF, a master regulator of chromatin 
structures and a key partner of PARP1 in regulating chromatin mobility, coordinate 








3 MATERIALS AND METHODS 
 
3.1   CELL CULTURES AND TREATMENTS  
 
HCT116 cells, kindly provided by Dr B Vogelstein, were cultured in complete growth 
medium (McCoy’s 5A modified medium (Thermo Fisher Scientific, 26600023)) 
supplemented with 10 % Fetal Bovine Serum (FBS) (Thermo Fisher Scientific, 16141079) 
and 1% penicillin-streptomycin (Life technologies). HCEC were grown in the presence of 
Colonic Epithelial Cell Medium (HCoEpiC, ScienCell, 2950) and Drosophila S2 cells 
(Thermo Fisher Scientific, R69007) in Schneider’s Drosophila medium (Thermo Fisher 
Scientific, 21720024) at the ambient temperature. hESCs (HS181, female) were cultured on 
irradiated male feeder fibroblasts and HEBs were generated as described previously(151). 
Cells were cultured at 37 °C under 5% CO2 and routinely tested mycoplasma 
contamination using EZ-PCR Mycoplasma Test Kit (Biological Industries, 20-700-20).  
 
Serum shock treatments were performed as described previously(115). Briefly, HCT116 
cells were cultured with serum-rich medium (McCoy’s 5A modified medium, 
supplemented with 50% horse serum (Thermo Fisher Scientific, 16050122)) for 2 hours. 
Cells were cultured with complete growth medium subsequently for indicated periods.  
 
HCT116 cells were treated with Olaparib (0.3 mM final concentration) for 24 hours, 
Flavopiridol (2 mM final concentration) for 8 hours, or 0.5 μM G9a enzymatic inhibitor 
BIX 01294 trihydrochloride hydrate (Sigma-Aldrich, B9311) for 72 hours before being 
harvested, as described in Paper I. The treatment with 10 μM β-catenin/TCF Inhibitor V 
(BC21) (Merckmillipore, 219334), or corresponding amount of DMSO in control cells were 
performed for 16h (Paper III). 
 
 
3.2   MUTATION OF THE OSE-SPECIFIC CTCF BINDING SITE BY CRISPR 
 
Key sequences within the main CTCF binding site at the OSE (chr8:128,219,114-
128,219,767) cells in Paper III were mutated using the CRISPR/Cas9 technology custom 





UAAACAGCAAUGCCCUCCAA, targeting the CTCF binding site within the OSE, was 
complexed together with the sp Cas9 to form a ribonucleoprotein (RNP). RNPs and donor 
DNA were then delivered to the cells via electroporation. Guide RNA cut location: 
chr8:127,215,101. The sequence within the CTCF binding site was modified from 




recovery for 2 days, the edits created were evaluated by PCR amplification off the edited 
site followed by Sanger sequencing. The edited cell pool was used to seed single cells for 
clonal expansion. Each well seeded was imaged every 2-3 days and rigorously tracked to 
ensure the population were truly clonal and only the progeny of a single cell. Resulting 
clones were verified using Sanger sequencing. Two clones (D3 and E4) were selected and 
expanded without using any selection agents.  
 
 
3.3   RNA/DNA FISH ANALYSES  
 
Probes for H19/IGF2, TLK1, VAT1L, PARD3, TARDBP, specific LADs and other 4C 
interactors in Paper I were generated based on bacterial artificial chromosome/clone 
(BAC).  Oncogenic super-enhancer (OSE), enhancer D (EnhD) and MYC probes in Paper II 
and Paper III were prepared from a pool of PCR products spanning 8 to 10 kb regions of 
Hind III sites encompassing the MYC promoter and gene body (chr8:128,746,000-
128,756,177), the OSE (chr8:128,216,526-128,225,855) and EnhD (chr8:128413009-
128414109), respectively. The PCR products were sonicated to 500-2000 bps range 
followed by labelling with Green 496-dUTP (Enzo, 42831), Cy3-dCTP (GE Healthcare, 
PA53031) or Cy5-dCTP (PA55021, GE Healthcare). The BAC probes were labeled with 
Biotin-16-dUTP (Roche, 11093070910), using Bioprime Array CGH kit (Life technologies, 
18095-011). A mixture of equal amounts of each labelled PCR product was used as the 
FISH probe and hybridized to formaldehyde cross-linked cells as described before(56). 
Finally, the cells were mounted in Vectashield mounting medium containing 4,6-





RNA FISH was carried on cells cultured on chamber slides (Thermo Fisher Scientific, 
154534) and crosslinked with 3% formaldehyde for 15 minutes at room temperature (RT). 
To inhibit ribonuclease activity, Ribonucleoside Vanadyl Complex (NEB, S1402S) was 
added to the buffers at all steps. Cells were permeabilized with 0.5% Triton X-100 in 
2xSSC for 10 minutes at RT. The FISH probe was mixed with a 10-fold excess of human 
Cot-1 DNA (Thermo Fisher Scientific, 15279011) and hybridization was carried on the 
slides, overnight at 37°C in a buffer containing 50% formamide, 10% dextran sulphate and 
2xSSC. Cells were washed twice first with 2xSSC/50% formamide at 40°C for 15 minute 
and then with 2xSSC for 15 minutes also twice at 40°C, followed by mounting with 
Vectashield mounting medium containing 4,6-diamidino-2-phenylindole (DAPI) (Vector 
Labs, H-1200).  
 
Crosslinking and permeabilization of the samples for DNA FISH analyses were performed 
as described for RNA FISH. After denaturation in 2 x SSC/ 50% formamide for 40 minutes 
at 80°C, cells were kept in ice cold 2 x SSC for 5 minutes. The hybridization and washing 
steps were prepared as described for RNA FISH.  
 
 
3.4    IN SITU PROXIMITY LIGATION ASSAY (ISPLA)  
 
To detect proximities between different proteins: CTCF-PARP1, CTCF-CTCF, PARP1-
PARP1 in Paper I and CTCF-AHCTF1 in Paper III cells that were crosslinked with 1% 
formaldehyde, blocked in 10% goat serum in PBS, 1h RT and incubated with antibodies of 
choice in 10% goat serum in PBS overnight at 4°C. Modified antibodies (termed R+ and 
M-) were added to the slides and further steps including hybridization of backbone and 
splint oligo DNAs, ligation with T4 ligase and rolling-circle amplification were perfumed 










3.5   CHROMATIN IN SITU PROXIMITY (CHRISP)  
 
ChrISP assays were performed and quantitated as previously described(153). Briefly, cells 
were crosslinked and permeabilized as for RNA/DNA FISH. After the hybridization of the 
FISH probes, the incubation with primary antibodies of choice was performed overnight at 
4°C. Next, similarly to the ISPLA technology, the cells were incubated with modified 
antibodies (termed R+ and M-), hybridized with backbone and green splinter and ligated, as 
described(153).  
 
3.6   GRID WIDE-FIELD MICROSCOPY  
 
In Paper I, cell imaging and generation of optical section in 3D were performed with the 
use of Leica DMI 3000B fluorescent microscope with OptiGrid device (Grid confocal) and 
analyzed in Volocity software (Quorum Technologies Inc). In Paper II and Paper III Leica 
DMi8 microscope with the Thunder Imaging System (Leica Microsystems) was used and 
pictures were analyzed with the use of Leica Application Suite X (LasX) software. Stacks 
were taken at 0.3 μm intervals in the Z-axis. 150-300 alleles were counted for distance 
measurements and/or ChrISP and ISPLA signal intensity in each case in Paper I, in Paper II 
app. 1800 alleles in three independent experiments and in Paper III 2740 alleles in two 
independent experiments were examined for DNA FISH proximity analysis. RNA FISH 




3.7   CHROMATIN NETWORKS AND INTEGRATION ANALYSES  
 
3.7.1 Circular chromatin conformation capture sequencing (4C-Seq)  
 
4C-seq analyses of chromatin interactomes in both HESCs and HEBs were performed as 
previously described(93), using the human H19 imprinting control region (ICR) region as 
bait. Briefly, formaldehyde crosslinking of examined cell lines was performed in the 
presence of presence of 4 mM Ribonucleoside Vanadyl Complex (S1402S, New England 





representing 106 formaldehyde-fixed hESCs or EB cells was carried for 2 weeks at 37°C 
with BglII, in the presence of 1 U/ml RNasin Plus (Promega). Removal of poly(ADP-
ribose) (PAR) was achieved by incubating the crosslinked chromatin with 25 ng/ml (final 
concentration) recombinant PARG 5 (catalog no. 4680-096-01, Trevigen) in the presence of 
2 mM DTT in BglII restriction buffer at 25°C prior to BglII digestion for 24h. For the 
RNase-treated samples, crosslinked chromatin was incubated with RNase A (0.8 mg/ml 
final concentration) during enzyme restriction. Further steps, including intra-molecular 





The identification of chromatin networks impinging on MYC and flanking enhancers was 
performed as previously described by Sumida et al.(154). Adaptation of the Nodewalk 
protocol for small input material included following steps: after formaldehyde fixation 
HCT116 cells were counted and diluted in nuclear isolation buffer with a final 
concentration of 600 cells/µl (corresponding to ca 3ng of genomic DNA/µl). The resulting 
cell suspension aliquots (0.5µl) were mixed and incubated for 10min, followed by direct 
10times x1.2 Buffer 2 dilution (New England Biolabs, Ipswich, MA. B7002S). Digestion 
with Hind III and subsequent ligation events were performed as previously 
described(56,154), but in a smaller reaction volume (20µl for Hind III digestion and 200µl 
for 3C ligation). After reverse cross linking, the 3C-DNA material was purified using the 
ChIP DNA Clean and Concentrator kit (Zymo Research, D5205), pre-heated at 65◦C with 
the elution buffer to increase the recovery of large DNA fragments. The control of digestion 
efficiency of cross linked chromatin(93) was performed by designing F1/R1 and F2/R2 
PCR primers (Table 1) flanking the Hind III sites at the 5` and 3`ends of the MYC promoter 
and gene body. Total DNA was quantified using the primers F3/R3 (Table 1) to produce a 
PCR fragment which lacks an internal Hind III site. To determine the digestion efficiency, 
the following formula was used: (1- (PCRF1+R1/F2+R2 /PCRF3+R3) × 100 (%). Libraries 
were generated by tagmentation as described earlier(56,154). The size distribution of the 
tagmented 3C DNA ranged from 200 to 300 bp. For the small input samples, Nextera XT 
DNA sample prep kit (Illumina, San Diego, CA. FC-121–1031, FC-131–1024) were used. 






library was performed on Illumina Miseq (Illumina) using the Miseq reagent cartridge v2 
(Illumina) that generated 140–150 bp paired-end reads. 
 
Table 1   PCR primers and conditions 
Type of 





95 °C, 5 min; (95 °C, 30 s; 65 




95 °C, 5 min; (95 °C, 30 s; 65 







95 °C, 5 min; (95 °C, 30 s; 65 
°C, 30s; 72 °C, 30 s) x 36 
H19 ICR TCACCCTGAGGCCAAGATCC 
CACGGGGGTCATC
AGGGATA 
95 °C, 5 min; (95 °C, 30 s; 65 




95 °C, 5 min; (95 °C, 30 s; 62 







95 °C, 5 min; (95 °C, 30 s; 62 




95 °C, 5 min; (95 °C, 30 s; 62 
°C, 30s; 72 °C, 30 s) x 36 
For allelic 
discrimination 
AD1 F1, R1 CCTCTCATCTCCCCAACCC 
CACCCGGATGGTG
CAGAATT 
95 °C, 5 min; (95 °C, 30 s; 57 
°C, 30s; 72 °C, 30 s) x 25 
AD2 F2, R2 CAACCCTCAATAGTGCACCCTG 
AGTGCAGGCTCAC
ACATCACAG 
95 °C, 5 min; (95 °C, 30 s; 68 












F1, R1 GACCCGGGGCCACGGGGCT 
TTTCAGCCTCCAG
ATGTGTG 
95 °C, 5 min; (95 °C, 30 s; 65 
°C, 30s; 72 °C, 30 s) x 36 
F2, R2 CAAGATCGAGCCATTGGAC 
AGGCAGGAAGAG
GGTCTGTC 
95 °C, 5 min; (95 °C, 30 s; 65 
°C, 30s; 72 °C, 30 s) x 36 
F3, R3 CCAACTCTGTCTTGCCTTCTT 
ACCCAAGCCACGC
GTCGCAG 
95 °C, 5 min; (95 °C, 30 s; 65 
°C, 30s; 72 °C, 30 s) x 36 
Detection of 





95 °C, 5 min; (98 °C, 10 s; 60 








X1, X2 ATGATAGAAACGGAAATATG 
AGTAGAATGCAAA
GGGCTC 
95 °C, 5 min; (95 °C, 10 s; 57 
°C, 30s; 72 °C, 30 s.) x 36 
Y11, Y22 AATCATCAAATGGAGATTTG 
GTTCAGCTCTGTG
AGTGAAA 
95 °C, 5 min; (95 °C, 30 s; 57 
°C, 30 
s 72 °C, 30 s) x 36 
ChIP-loop ICR-Vat1L GCCTGCCTCTGGACTCTGAGACTGG 
CCACTGCTCAGCC
TTAGAGGAA 
95 °C, 5 min; (98 °C, 10 s; 60 
°C, 20 
min; 68 °C, 5 min). x 5 ; (98 °C, 
10 s; 







94 °C, 3 min 
(98 °C, 20 s; 70 °C, 20 min; 68 
°C,  
20 min.) x4; 
(98 °C, 20 s; 70 °C 90 s; 68 °C, 
20 min.) x 25 
Nest 1 GATTAGGCTCCCAGCCATGCATG 
GGGTCATCTGGGA
ATAGGACACTC 
94 °C, 3 min 
(98 °C, 20 s; 58 °C, 90 s; 68 °C,  
20 min.) x 27 
Nest 2 GATAAGAGCGAAACTCTGTC 
CACTCATGGGAGC
CGCAC** 
94 °C, 3 min 
(98 °C, 20 s; 56 °C, 60 s; 68 °C,  
20 min.) x 26 
Nest 3 CAGAAAATTATGACAATGAAAG 
CACTCATGGGAGC
CGCAC** 
94 °C, 3 min 
(98 °C, 20 s; 59.5 °C, 30 s; 68 
°C,  





94 °C, 3 min 
(98 °C, 20 s; 70 °C, 20 min; 68 
C,  
20 min.) x 4; 
(98 °C, 20 s; 70 °C, 90 s; 68 °C, 
 20 min.) x 19 
Nest 1 GGGTAATAAAGGAATAACTTGGGTGC 
GCACCCAAGTTAT
TCCTTTATTACCC 
94 °C, 3 min 
(98 °C, 20 s; 60 °C, 90 s; 68 °C,  
20 min.) x 20 
Nest 2 GGCTTGGACATATTTGCTATTTTG 
CTATTCAGTGTGC
TGCTGCAAG 
94 °C, 3 min 
(98 °C, 20 s; 56 °C, 60 s; 68 °C, 
20 min.) x 20 
Nest 3 GGAGCAAAGTCAAAGGAGAGATC 
CCATCTCCAATAT
GACTGAAGATC 
94 °C, 3 min (98 °C, 20 s; 55 °C, 
60 s; 68 °C, 









3.8   IMMUNOPRECIPITATION ANALYSIS 
 
3.8.1 ChIP-qPCR  
 
The collection of cells and their fixation with freshly prepared 1% formaldehyde solution 
was performed as described previously(93). The immuno-purification of the DNA-protein 
complexes used the following antibodies: in Paper I - PAR polymer (4336-BPC-100, 
Trevigen), CTCF (sc-15914, SantaCruz Biotechnology, BD), Rad 21 (Abcam) or PARP1 
(ALX-210-221-R100, Alexis) and Dynabeads○,R Protein G (Invitrogen); in Paper III - 
CTCF (Abcam, ab155990), AHCTF1 (Novusbio, NBP1-87952), ß-catenin (Novus Bio 
#NBP1-87952) or TCF4 (Santa Cruz, sc-8631) and Dynabeads protein G (Thermo 
Sciences, 10004D), as described(155). The purification was performed with ChIP DNA 
Clean and Concentrator (Zymo Research, D5205), and quantification by standard qPCR 
analysis using primer sequences and PCR conditions, as previously described(56).  
 
3.8.2 Co-immunoprecipitation (co-IP) assay 
 
Co-IP assays were performed using the Nuclear Complex Co-IP kit, following the 
manufacturer’s recommendation (54001, Active Motif). Briefly, 400 μg (Paper I) or 250 μg 
(Paper III) of nuclear lysates were used in the analyses. The pre-clearing of the material 
was done by the addition of Dynabeads Protein G (Thermo Fisher Scientific, 10004D). In 
Paper I, anti-CTCF (2899S, Cell Signalling) and in Paper III anti-CTCF (Abcam, ab37477, 
mouse), anti-NUP133 (Abcam, ab114096, rabbit), anti-AHCTF1 (Novus Bio, NB600-238, 
rabbit), normal rabbit IgG (Cell Signaling, 2729S) and normal mouse IgG (Santa Cruz, sc-
2025) were used. Where indicated, extracts were incubated with Olaparib at final 
concentration (0.3 μM) during the washes. The immunoprecipitated material was analyzed 
by Western blot (Paper I) or Simple Western assay using the WESTM system 








3.9   WESTERN BLOT ANALYSIS 
 
In Paper I, protein analyses were performed by SDS-PAGE using “any kD” Criterion TGX 
Gel (567-1125, Biorad). Transfer of separated proteins to polyvinylidene difluoride 
membranes (162-0174, Biorad) was carried out overnight at 4◦C at 200 mA. The 
membranes were blocked overnight incubation in TBST (10mM Tris-HCl, pH 8.0, 150mM 
NaCl, 0.05% Tween 20) containing 7% skim milk followed by overnight incubation at 4◦C 
with antibodies against alpha-tubulin (T6199, Sigma Aldrich), beta-actin (4967L, Cell 
Signaling Technology), CTCF (2899S, Cell Signaling), PAR (4336- BPC-100, Trevigen), 
or PARP1 (ALX-210-221-R100, Alexis) diluted in TBST and 7% skim milk. The 
membranes were washed with TBST 3 times, 10 minutes each. Identification of the signal 
was achieved by incubation with secondary antibodies conjugated to horseradish 
peroxidase against mouse IgG (AP308P, Millipore) or rabbit IgG (7074S, Cell Signaling 
Technology), and its visualization by using ECL Prime Western Blotting Detection reagent 
(RPN2232, GE Healthcare) captured by LAS-1000 (Fuji Film). The signals were quantified 
by Quantity One software (BioRad). 
 
In Paper III, protein analyses were performed with Simple Western assay using the WES™ 
system (ProteinSimple, Bio-Techne) using the anti-CTCF (Cell Signaling, 2899S, rabbit), 
anti-PARP1 (Abcam, ab32071, rabbit), anti-NUP133 (Abcam, ab155990, rabbit), anti-
AHCTF1 (Novus Bio, NB600- 238, rabbit) and anti-β-catenin (Cell Signaling, 8480S, 
rabbit) antibodies. The acquired chemiluminescence signal was measured and analyzed 
using the Compass software for Simple Western (ProteinSimple, Bio-Techne). The 
identification of chemiluminescence peaks corresponding to analyzed protein was obtained 
by configuration of default setting and production of standard curve based on serial 











3.10  RNA ANLYSES  
 
3.10.1 siRNA transfection 
 
Where indicated, CTCF siRNA(h) (sc-35124), PARP1 siRNA(h) (sc-29437) or GFP siRNA 
(sc- 45924) from Santa Cruz Biotechnology were transfected into the analyzed cells by 
using Lipofectamine RNAiMAX Transfection Reagent (13778075, Life Technologies), 
following the manufacturer’s instructions. Briefly, when cells reached 20% confluency, 20 
pmol of each siRNA- Lipofectamine complex was added to the cell culture. After 6h of 
lipofection, medium was replaced with McCoy’s 5A modified medium (16600-082) 
supplemented with 10% fetal bovine serum (FBS) and penicillin-streptomycin and cells 
were harvested for further analysis 48 hours after transfection. The efficiencies of the 
siRNA transfections were validated by immunostaining analysis. 
 
 
3.10.2 Pulse labeling of RNA and nuclear RNA export assay 
 
Newly synthesized RNA samples were obtained by incubating the cells with 0.5 mM (at 
final concentration) 5-ethynyl uridine (EU, Thermo Fisher Scientific, E10345) for 15 or 30 
minutes. Following this pulse, the cells were washed with 5xPBS and incubated with pre-
warmed normal growing medium for indicated time periods. The fractionation of EU-
labelled nuclear and cytoplasmic RNA followed by cDNA synthesis and RTQPCR-
analyses of the presence of intronic and exonic regions of MYC enabled analyses of the 
kinetics of the nuclear export of newly synthesized RNA (determined by the 
cytoplasmic/nuclear ratios). The separation of the nuclear and cytoplasmic fraction as well 
as the isolation of newly labeled RNA used the Ambion® PARISTM system (Thermo 
Fisher, AM1921), according to the manufacturer's instructions. The capturing of EU-
labelled RNAs was performed by Click-iT Nascent RNA capture kit (Thermo Fisher, 
C10365) followed by conversion into cDNA using SuperScript VILO cDNA Synthesis Kit 







3.10.3 RT-qPCR analysis of transcription  
 
The quality of purified RNA samples was measured before cDNA synthesis by SuperScript 
VILO cDNA Synthesis Kit (Life Technology, 11754050) using Bioanalyzer 2100 
(Agilent). All the qPCR examinations were done by using 10-fold diluted cDNA and iTaq 
Universal SYBR Green Supermix (Bio-Rad, 1725125) on RotorGene 6000 (Corbett 
Research). Serial dilutions of sonicated genomic DNA were used to ensure the linear range 











4.1 PAPER I: PARP1- AND CTCF-MEDIATED INTERACTIONS BETWEEN 
ACTIVE AND REPRESSED CHROMATIN AT THE LAMINA PROMOTE 
OSCILLATING TRANSCRIPTION 
 
4.1.1 Inter-chromosomal interactome and connection between circadian loci and 
repressed domains 
 
The analyses of dynamic chromatin crosstalk was performed using the 4C technique, which 
allows the capturing of more than two simultaneously interacting chromatin 
fibers(38,93,94). The H19 ICR, used as a bait in human embryonic stem cells (hESCs) and 
human embryoid bodies (hEBs), was chosen as it confers epigenetic changes in trans in the 
mouse(156) (G&D 2009 paper). We identified 518 different regions which were 
reproducibly interacting with the bait in a developmentally regulated manner. The 
interactome included both intra- and inter-chromosomal interactions, the latter of which 
dominated the chromatin network(157). The sequences within the 4C libraries covered both 
genes and intergenic regions and were enriched in transcriptional units controlling cell 
adhesion/synaptic processes. The created network was approximate scale-free and 
characterized by a high modularity. Although the interactome represented the sum of 
interactions within a cell population, where individual interactions are likely variable and 
dynamic at the single cell level, multiple interactions emerged reproducibly in two or more 
4C samples as central nodes of the network.  
 
To validate the network, 3D DNA FISH analyses were performed. Analysis of the physical 
distance between the bait and its interactors showed that the nodes with high count reads in 
4C library (representing central nodes with higher connectivity) were significantly closer to 
the bait than the sequences having low read counts. To further validate the topology of the 
network we generated new chromatin interactome data using new 4C bait, the locus coding 
vesicle amine transport 1 homolog-like protein (VAT1L), which connected to every module 
of the H19 ICR interactome. Indeed, apart from the reproduction of the modules discovered 
using the H19 ICR as bait, the VAT1L bait discovered new regions independent from the 
H19 ICR interactome. Finally, 3D DNA FISH analyses showed that regions more distal in 





the H19 ICR bait in contact with only a subset of loci at any given time. A unique feature of 
the H19 ICR 4C network was its coverage of various chromatin states. Interactions with 
both transcriptionally active and inactive chromatin components neither segregated away 
from each other neither showed preferences in both human embryonic stem cells (hESC) 
and derived embryoid bodies (hEBs). This observation uncovered an exceptional feature of 
the H19 ICR interactome by questioning the dogma that active and inactive domains are 
always separated(39,157)  
 
 
4.1.2 Role of CTCF and PARP1 interactions in connecting circadian loci to LADs 
 
The high reproducibility of the 4C network highlighted the possibility that encounters 
between the nodes might be regulated. Taking into the account the role of PARylated 
CTCF, accompanied by its ability to complex with PARP1 to regulate the insulator of the 
maternal H19 ICR(158), we hypothesized that PARylation and/or PARP1 together with 
CTCF might organize chromatin network in trans. Indeed, removal of PAR chains from 
formaldehyde cross-linked chromatin by PAR glycohydrolase (PARG)(159) disassembled 
the network in both hESC and hEBs in a manner distinct from that produced by RNase 
treatment. These data indicated that PAR is present in the H19 ICR chromatin fibre 
interactome. However, this observation didn’t discriminate whether PARylation was the 
cause or consequence of upcoming chromatin fibers interaction. To explain the mechanism 
of PAR deposition as well as the role of CTCF/PARP1 interactions in establishing the inter-
chromosomal network, several experiments were performed. First, we could show that 
CTCF can activate PARP1 but not PARP3 in the absence of DNA damage, reinforcing the 
notion that PARylation of chromatin depends on CTCF/PARP1 interactions. Moreover 
down-regulation of CTCF by small interfering RNA (siRNA) reduced cellular PAR levels, 
indicating that CTCF is a major regulator of PARP1 activity in the living cell. In parallel, 
ChIP-loop analysis documented that PARP1 is a part of H19 ICR-VAT1L complex, whereas 
3D DNA FISH revealed that Olaparib treatment not only inhibits the enzymatic activity of 
PARP1 but also disrupted CTCF/PARP1 interactions in both co-immunoprecipitation and 
in situ proximity ligation assay experiments(160). Moreover, Olaparib treatment 
significantly reduced the proximities between IGF2/H19-VAT1L loci as well as between 





control. Since Olaparib treatment affected also the relative positions of VAT1L and 
IGF2/H19 in relation to their chromosome territories we concluded that CTCF/PARP1 
interactions and/or PARP1 activity regulates chromatin movements. Accordingly, 
chromatin immunoprecipitation (ChIP) analysis demonstrated that PARP1 binds to many of 
the chromatin hubs in the 4C network, including VAT1L and H19 ICR. Moreover, CTCF 
binding to some of the H19 ICR-interactors was disrupted by a 24-hours Olaparib treatment 
indicating indirect binding to these regions. Even only 10-min incubation with Olaparib 
during the formaldehyde cross-linking of 4C material disassembled most of the chromatin 
interactions in hESCs. All these observations taken together demonstrate that the 
CTCF/PARP1 complex plays important roles in the establishment of the H19 ICR 
chromatin network and that PAR chains likely both stabilize these interactions and 
diversify the network by providing a platform for interactions. 
 
Discovery of extensive interactions between transcriptionally active and inactive chromatin 
components within 4C network suggested that the communication between examined loci 
might function to fine-tune transcription. Due to the fact that PARP1 was found to be 
involved in the entrainment of circadian rhythms to feeding in mouse(161) we examined 
our network for circadian genes. Indeed, permutation-based enrichment analyses showed an 
over-representation of circadian genes involved in lipid metabolisms, particularly in 
flanking regions 10 kb or less from the site of interaction. Remarkably, circadian genes 
frequently interacted with repressed domains and constitutive LADs, and the percentage of 
these interactions was higher than between circadian genes. 3D DNA FISH analyses 
confirmed this pattern by demonstrating frequent, PARP1-dependent proximities between 
VAT1L and four different constitutive LADs at the nuclear periphery. 
 
 
4.1.3 CTCF/PARP1 mediated circadian transcriptional attenuation by oscillating 
repositioning of circadian loci to the nuclear periphery 
 
We therefore considered the link between the role of the nuclear periphery in the dynamic 
regulation of gene transcription(46,48), and repressive chromatin modifiers interacting with 
the core clock machinery (co-regulating the negative limb of the circadian feedback 





might require the recruitment of circadian loci to the nuclear lamina to attenuate their 
transcription in oscillating manner. To explore this possibility, we used the method of 
serum shock synchronization of circadian gene expression in cultured HCT116 cells(115). 
In contrast to hESCs, for example, the HCT116 cells displayed prominent circadian 
expression profiles. Using in situ proximity ligation (ISPLA) we first documented that the 
proximities between CTCF and PARP1 were under circadian control peaking at 8 and 32h 
and could be found primarily at the nuclear periphery. Similarly, 3D DNA FISH analyses 
showed that the serum-shock induced the rhythmic juxtaposition of IGF2/H19, VAT1L, 
PARD3 and TARDBP to the nuclear periphery. Interestingly, the examined loci showed 
different timing of recruitment to the periphery - 0h and 24h peaks for IGF2/H19 and 
VAT1L, while PARD3 and TARDBP peaked around 8h later. Because IGF/H19 and VAT1L 
exhibited low transcriptional activity in contrast to PARD3 and TARDBP in HCT116 cells, 
we examined if inhibition of transcriptional elongation by Flavopiridol(164) would affect 
PARD3 and TARDBP tethering to nuclear lamina. Indeed, Flavopiridol treatment 8h before 
harvesting the serum-shocked cells not only inhibited transcription, but also accelerated the 
movement of these two loci to the nuclear periphery. These results show that transcriptional 
activity or transcription-associated processes delay the mobility of circadian loci towards 
the nuclear periphery. Olaparib treatment and CTCF or PARP1 knock-down, on the other 
hand, not only abolished rhythmic juxtaposition of circadian loci to the lamina, but also 
disrupted rhythmic transcription of PARD3. All of these findings document that CTCF and 
PARP1 join forces to control both the rhythmic repositioning of circadian loci to the 
nuclear lamina and the entrainment of circadian transcription. 
 
Interestingly, transcriptional attenuation of PARD3 did not occur immediately following its 
recruitment to the nuclear periphery. Using a higher precision in the time course, we could 
show that its transcriptional activity was highest when juxtaposed to the lamina to 
significantly drop a few hours later while still juxtaposed to the nuclear periphery. To 
further investigate this observation, we examined the presence of repressive chromatin 
marks on the PARD3 locus in HCT116 cells, which are typically enriched at nuclear 
periphery. Since ChIP analyses revealed the presence of the H3K9me2 mark but not the 
H3K27me3 mark at PARD3, we used the ChrISP technique(153) to document that the 
H3K9me2 mark peaks at PARD3 at the time of its transcriptional attenuation while still 





coincided with an increase of PARD3 transcriptional activity when returned to the interior 
of the nucleus. Importantly, the inhibition of enzymatic activity of G9a/Glp by 
BIX01294(165) not only depleted the H3K9me2 mark and reduced the amplitude of 
oscillation in PARD3 transcription, but also abolished its movement to the periphery. In 
summary, the data demonstrates that the juxtaposition of PARD3 to the nuclear periphery is 
accompanied by a time-dependent acquisition of the repressive H3K9me2 mark and 
rhythmic transcriptional attenuation. 
 
 
4.2 PAPER II: MYC AS A DRIVER OF STOCHASTIC CHROMATIN NETWORKS: 
IMPLICATIONS FOR THE FITNESS OF CANCER CELLS 
 
 
4.2.1 MYC-driven chromatin networks as a sum of stochastic interactions 
 
The active MYC locus, which is under circadian control(150), has an ability to form 
networks enriched in flanking enhancers(56,101). To identify the most important nodes in 
the MYC network, we used the Nodewalk technique to create virtual chromatin networks in 
primary cultures of human colon epithelial cells (HCECs) as well as in a colon cancer cell 
line (HCT116). Due to the fact that MYC is diploid in HCECs but triploid in HCT116 cell 
line we randomly sampled two-thirds of the interactions from the HCT116 network, hence 
compensating for any possible bias. The analysis showed that the most connected nodes are 
more prominent in HCT116 than in HCEC, and increasing k-core (a parameter which 
identifies the most connected nodes(166)) correlated with strong enrichment of primed and 
active enhancers. To uncover which nodes were crucial for establishing the topology of the 
network, and hence the removal of which nodes would globally affect the network 
structure, we used the dynamic index approach for distinguishing the most influential 
regions(167). Contrary to expectations that enhancers would drive the network, MYC itself 
came up as the most dynamic information spreader within the network indicating that MYC 






To pursue this finding to the next level, we wanted to rule in or out that the MYC chromatin 
network represented the sum of stochastic interactions present only in large cell population. 
To this end, we developed and applied a modified Nodewalk protocol(56,154), to enable 
the analyses of very small input samples and yet preserve high reproducibility. We 
generated three types of samples - 1. A set of samples with large input material, 
representing technical replicates; 2. Ten samples with small input material derived from a 
large pool of ligated DNA corresponding to one million cells, which was aliquoted to 
generate ten samples, each containing 0,88ng of DNA (app. 176 cells), also representing ten 
technical replicates; 3. Nine biological replicates starting from independently prepared 
small cell populations, corresponding to 177 cells. As the MYC chromatin network is 
dominated by interactions in cis, our focus on the presence of flanking interactors in 
technical replicates from the same initial RNA library (prepared from 0,88ng of 3C DNA), 
generated a technical reproducibility >90%. Additionally, analyses of nine 177-cells 
samples showed that >70% of MYC interactions were present in only one library, while in 
ten 0,88ng 3C DNA technical replicates >85% of interactors were reproduced in two or 
more libraries. Importantly both set of samples exhibit a comparable proportion of 
interaction categories, and the overlap between the pooled 177-cells biological replicates or 
the pooled 0,88 technical replicates and the large input technical replicates generated from 
3C DNA aliquots (corresponding to 10 000 cells) exceeded 91%. These data indicated that 
the small-input Nodewalk protocol could be reliably used to recapitulate the interactors 
already present in high-input network. Thus, interactomes uncovered in the large input cell 
populations represented only the sum of stochastic interactions present in individual cells. 
 
 
4.2.2 Mutually exclusive interactions of MYC with flanking enhancers 
 
Examination of stochastic interactions faces significant challenges - the smaller the sample 
is the more variable results can be obtained to compound reproducibility. However, having 
proven the high reproducibility of the modified Nodewalk technique we decided to further 
reduce the input sample to 34,8pg which corresponds to 21 alleles in seven cells. By 
comparing 23 aliquots of such samples the 9x177 batch of cells, 6 out of 8 different 
interactors within TAD1 or TAD2 flanking MYC overlapped. Moreover, the number of 





the average recovery of the bait was 36,2%, 0,7 enhancer region interacted with 7.6 
different MYC alleles. These numbers and the high similarity between the binned data of 
high and small-input material demonstrate that MYC interacts with its enhancers in a 
dynamic and mutually exclusive manner. This conclusion was reinforced by 3D DNA FISH 
analyses demonstrating that the proximities between MYC and its two major interactors – 
the oncogenic super-enhancer (OSE) and enhancer D (EnhD)(56,154) – rarely, if at all, co-
localize in the nuclear space, within the limits of microscopic resolution. All of these 
observations taken together disprove the concept of enhancer hubs simultaneously 
impinging on MYC, showing that synchronous interactions of many enhancers with the 
MYC locus are only virtual consequence of larger cell population analysis and represent the 
sum of stochastic events occurring in smaller populations. 
 
 
4.3 PAPER III: A CTCF BINDING SITE WITHIN THE ONCOGENIC SUPER-
ENHANCER COORDINATES THE WNT-REGULATED GATING OF MYC 
 
4.3.1 CTCF regulates the WNT-dependent pre-nucleoporin-OSE interactions   
 
Scholz et al. (56) documented the existence of an oncogenic super-enhancer-mediated 
mechanism that recruits the MYC gene to nuclear pores under the control of the WNT 
signaling pathway in human colon cancer cells. To explore the inner workings of this 
process, we focused on CTCF, which regulates both enhancer-promoter 
communication(168) and chromatin mobility within the nuclear architecture (Paper I). Our 
initial analyses in HCT116 cells showed that CTCF not only interacts with Nucleoporin 
133 (NUP133) and AT Hook Containing Transcription Factor 1 (AHCTF1 or ELYS), 
which are pre-nucleopore complex members involved in MYC gating, but also with ß-
catenin, a key player in the WNT-dependent gene gating of MYC. Interestingly, ISPLA 
analysis showed that periphery-specific proximity between CTCF and AHCTF1 can be 
significantly reduced upon treatment with the BC21 drug(169) which interferes with 
downstream ß-catenin and TCF4 interactions in the WNT canonical pathway. We therefore 
focused on a single CTCF binding site within a region of the oncogenic super-enhancer 
(OSE) physically interacting with MYC (Paper II). Using CRISPR technology(170) to 





carrying mutant OSE alleles which lost almost all of their ability to bind CTCF while 
leaving CTCF binding to the MYC promoter unaffected.  
 
 
4.3.2 CTCF coordinates several steps of the WNT-regulated gating of MYC   
 
Next, we wanted to examine if the mutation of the OSE-specific CTCF binding site had an 
impact on the nuclear export of MYC mRNA into the cytoplasm. To this end, we 
performed nuclear export assays described before(56), exploring the cytoplasmic/nuclear 
ratios between newly synthesized MYC transcripts, The results showed that even though the 
overall transcriptional rate of MYC was not significantly affected in both mutant cell clones 
compared to control cells, the mutant OSE alleles were unable to support the facilitated 
nuclear export of MYC mRNA, showing a three-fold reduction in comparison to the wild 
type allele. Moreover, since the addition of BC21, which inhibits the canonical function of 
the WNT signaling pathway (163), did not further change the export rate in the D3 and E4 
clones, we conclude that WNT regulates MYC gating via the OSE-specific CTCF binding 
site. Moreover, computer simulation showed that the observed changes in total MYC 
mRNA expression between wild type and mutant cells was solely dependent on the loss of 
the rapid nuclear export of MYC mRNA 
 
Our lab has previously shown that the MYC and OSE regions display highest potential for 
interactions when juxtaposed to the nuclear periphery(56). While we could confirm this 
observation in wild type cells, the mutant cells showed both loss of OSE and MYC 
proximity to each other and a reduced presence of these regions at the nuclear periphery. 
These findings were independently validated by using the ChrISP technique, which has a 
higher resolution in all three dimensions. Finally, Olaparib treatment of the cells revealed 
loss of facilitated nuclear export of MYC mRNA, indicating that the CTCF-PARP1 








5.1  NUCLEAR PERIPHERY AND ITS ROLE IN THE REGULATION OF GENE 
EXPRESSION 
 
Despite its huge size, the human genome enclosed by the nuclear double membrane is 
tightly compacted but non-randomly organized within the nucleus. In mammals, the nuclear 
periphery is enriched in a unique set of inner nuclear membrane (INM) proteins (e.g., lamin 
B receptor – LBR and lamina associated peptide 2 - Lap2; emerin) which interact with the 
nuclear lamina consisting of a filamentous meshwork of nuclear lamins: A-type lamins 
(lamina A and C) and B-type lamins (lamin B1 and B2)(171–173).  
 
Accumulating evidence supports a role for the nuclear membrane to function not just as a 
passive barrier, but also as a dynamic interface which modulates gene activity and 
chromatin organization. Thus, both experimental (3D-DNA FISH) and bioinformatic 
analyses showed that gene-rich chromosomes and early replicating genes are more centrally 
deposed, while gene-poor chromosomes and late replicating genes are preferentially located 
at the nuclear periphery being part of LADs(171,174,175). It therefore appears that LADs 
are formed not just as a result of gene inactivity but represent an intrinsically repressive 
nuclear domain. In line with this reasoning, the insertion of a reporter gene within a LAD or 
gathering an entire chromosome to the nuclear periphery reduces its expression compared 
to that when they are positioned in the nucleoplasm(53,176). Moreover randomly integrated 
sequences delivered from LADs have an ability to tether to the lamina and undergo 
transcriptional repression(172,177).  
 
Nevertheless, despite these examples of primary repressive functions, the nuclear periphery 
has also been shown to function in gene activation(178). While association with the lamina 
is almost always repressive(179), relocation of certain loci to the Nuclear Pore Complex 
(NPC) might either activate or repress genes(172). NPCs are major transport tracks between 
the nucleus and the cytoplasm(180) consisting of 32 copies of each of ca 30 nucleoporins 
proteins (NUPs) in mammals to form a huge protein complex. The complexity of the 





of heterochromatin exclusion zones, regulation of RNA splicing as well as RNA export and 
its associated phenomenon of gene gating(56,172).  
 
The importance of the regulatory functions of the nuclear periphery is highlighted in Paper 
I and Paper III. We could thus show that the rhythmic migration of circadian loci to the 
nuclear periphery and their interactions with LADs promotes circadian transcriptional 
attenuation, indicating that the repositioning of active circadian genes to the repressive sub-
compartment facilitates chromatin transitions from the positive to the negative limb of the 
circadian rhythm. These findings also highlight a novel function of the repressive gene 
deserts at the lamina in the regulation of the circadian expressivity of the genome. As 
circadian genes remained active for several hours at the lamina before their repression, we 
hypothesized that they might first land on transcriptionally permissive environments, such 
as nuclear pores. Paper III explores the mechanism of such gene gating events at the MYC 
gene, highlighting the role of CTCF and PARP1 in this process. Given the circadian 
expression of MYC in several model systems, it is thus plausible that the gating process is 
also under the control of the circadian clock. It remains to be seen whether the circadian 
genes that undergo rhythmic recruitment to the lamina also undergo facilitated export to the 
cytoplasm and to what extent this mechanism contributes to oscillating gene expression 
genome wide.  
 
Given the role of CTCF7PARP1 complexes in the recruitment of circadian loci to the 
lamina, circadian-dependent changes in the nuclear architecture contribute not only to 
transcriptional plasticity, but also connect the 3D chromatin structure at the lamina with the 
metabolic states of the cell (PAPER I, III,(181)). These considerations include also the 
CTCF- and PARP1-regulated gating of MYC to the nuclear pores (PAPER III). As 
metabolic processes tend to be under circadian control, these findings indicate that there 
might be a two-way relationship between cellular metabolic states and circadian 3D 








5.2  COORDINATION OF ENHANCER-PROMOTER INTERACTIONS AND SUB-
NUCLEAR LOCALISATION AT THE MYC LOCUS  
 
It remains a fundamental question how enhancer-promoter interactions are integrated 
within the 3D nuclear architecture and how such processes are coordinated with chromatin 
mobility between active and repressive sub-compartments. Paper II shows that MYC 
screens for enhancers in its flanking TADs in a stochastic process resulting in that MYC 
interacts with one enhancer at a time. The often observed existence of the so-called 
enhancer hubs are thus likely only a virtual feature of large cell populations that does not 
exist in single cells. Application of the ultra-sensitive Nodewalk protocol also revealed that 
<10% of MYC alleles interacted with an enhancer at any given time to highlight the 
dynamic character of enhancer-gene interactions. Interestingly, the loss of the functional 
cohesin complex has earlier been shown to generate super-enhancer clusters forming 
hundreds of links within and across chromosomes(182). This data therefore suggests that in 
the presence of the cohesin complex, genes are preferred partners for enhancers, but that in 
its absence enhancer hubs might be formed even in single cells. By extrapolation, the 
enhancer hubs night therefore represent situations with a normally occurring, transiently 
reduced presence of the cohesin complex at these regions. This discussion is compounded 
by a previous observation of our lab, that different enhancers display different functions 
depending on the intra-nuclear position of MYC(56). One category of enhancers, such as 
Enhancer D, thus showed proximity to MYC preferentially in intra-nucleoplasmic locations 
to potentially contribute to the transcriptional activation of MYC. Conversely, the oncogenic 
super-enhancer showed preferential proximity to MYC at the nuclear periphery/pore to post-
transcriptionally facilitate the nuclear export of its derived mRNA(56). 
 
These observations raise a Pandora’s box of questions. For example, how is the dynamic 
process of the repositioning of the MYC locus to the nuclear periphery regulated and 
coordinated with its interactions in cis and trans? The observations that partly or 
completely processed MYC transcripts are highly enriched while still proximal to their 
templates at the nuclear periphery indicate that MYC transcript processing requires 
movement of their templates(56). Since transcriptional activation of MYC is largely 
occurring in the nuclear interior, we speculate that the elongation process might be 





analogous to our earlier observation, that transcriptional inhibition by Flavopiridol 
facilitates the migration of circadian loci to the nuclear periphery (Paper I). Similarly, X 
chromosome inactivation in female mammalian cells is accompanied by relocation of the 
inactive X to the nuclear lamina during early development(172,183). It is also noteworthy 
that damaged DNA, represented by compromised telomeres, for example, can explore large 
volumes of the nucleus within minutes to hours(184). However, it remains to be established 
if the migration of MYC to the nuclear pores is the result of inhibition of transcriptional 
elongation and/or controlled DNA damage. In line with the latter reasoning, the role of 
PARP1 in the migration of circadian loci to the nuclear periphery (Paper I) might provide 
an opening. Finally, it has been shown that nuclear ß-actin is involved in the regulation of 
interactions between heterochromatin and the nuclear envelope(185). Our unpublished 
ISPLA data show that CTCF and G-actin have a high potential to form complexes with 
each other. This is of particular interest since the rhythmic pattern of nuclear ß-actin levels 
is inverse to that of the cytoplasmic F-actin(186). Taken together, these observations 
indicate that the migration of MYC to the nuclear pores might be indirectly regulated by 
cytoplasmic F-actin polymers to promote or antagonize nuclear CTCF-ß-actin complexes.  
 
 
5.3  THE ROLES OF CTCF AND PARP1 IN THE REGULATION OF CHROMATIN 
NETWORKS AND THEIR SUB-NUCLEAR LOCALIZATION 
 
In Paper I and III we make the point that CTCF and PARP1 play important roles in both the 
regulation of chromatin interactions and the mobility of the interactors. In Paper I we 
uncovered novel principles, in which the repositioning of active circadian loci to inactive 
LADs at the nuclear periphery is regulated by CTCF and its binding partner PARP1, 
thereby promoting transcriptional attenuation. In Paper III we show that a single CTCF-
binding site within the OSE coordinates WNT-regulated MYC gating. Although it is well 
established that CTCF functions as a master regulator of the genome, setting up chromatin 
boundaries and gene expression domains, its involvement in regulating chromatin mobility 
is currently an unchartered territory. One clue to this feature might be provided by the 
involvement of PARP1 in these processes, as highlighted in Papers I and III. However, the 
inner workings of this process are completely unknown. Although the CTCF-ß-actin 





directionality of the migration to the nuclear pore. It is important to note that MYC appears 
to be a passive passenger with the oncogenic super-enhancer driving the migration of the 
entire region to the nuclear periphery. Thus, whereas the cohesin complex is likely involved 
in the formation of the OSE-MYC complex at the nuclear periphery, it does not likely 
provide the main driving force of the OSE juxtaposition to the nuclear pores. Interestingly, 
however, the cohesin complex harbors ATPase activity and that its chromatin loop 
extrusion function requires ATP(187,188). The activation of PARP1 by CTCF results in the 
production of poly(ADP-ribose) chains that have previously been shown to provide local 
supplies of ATP, coordinated by the PARG enzyme, during the DNA repair process, for 
example(189,190). Such locally high levels of ATP might fuel the function of the cohesin 
complex to coordinate subnuclear localization with OSE-MYC interactions.  All of these 
data suggest that CTCF/PARP1 interactions and the consequent generation of PAR might 
play an important role in the coordination of chromatin mobility and enhancer-promoter 
communication.  
 
5.4  THE DYSREGULATION OF CHROMATIN STRUCTURES IN DISEASES 
 
The 3D chromatin structure plays an important role in orchestrating nuclear processes, 
particularly those involved in gene expression outputs stabilizing phenotypes. Although 
still underestimated, abnormalities in the spatial organization of the genome might underlie 
many diseases by impeding correct sets or promoting unscheduled sets of interactions 
between genes and regulatory elements(171,172,191). As a master genome organizer, 
unscheduled methylation events of CTCF binding sites to antagonize CTCF binding are a 
common source of abnormal chromatin organization, by globally disrupting TAD 
organization and chromatin insulation(191). CTCF is a key factor in life, as homozygous 
knockouts are lethal already during pre-implantation development(192). Moreover, patients 
displaying CTCF haploinsufficiency exhibit developmental defects such as intellectual 
disability or growth retardation(191,193). Mutations in one or more of the eleven zinc-
fingers of CTCF are frequently associated with different cancer types, and CTCF sensitivity 
to CpGs hypermethylation could be linked to human gliomas (with global 







Importantly, we could show that CTCF is also involved in the circadian rhythm dependent 
chromatin movement regulation. Paper I thus highlights a new principle of gene regulation 
that should be considered when treating cancer patients, for example. Due to the rhythmic 
transcriptional activity of circadian genes, timed chemotherapy treatments might be 
beneficial for the patient by optimizing the function of the treatment when circadian genes 
are at the periphery, for example, while simultaneously reducing its side effects. This 
approach could increase the efficiency of cancer cell elimination to the provided drug, thus 
increasing the chance for the successful treatment. 
 
The unscheduled disruption of nuclear compartments might also lead to various 
pathologies. Over 400 different mutations of nuclear lamina components were linked to 
different laminopathies, where the majority of them affected lamin A/C (191). Lamina-
associated mutations are the cause of disorders such as Hutchinson-Gilford progeria 
syndrome (HGPS) characterized by premature aging or Emery-Dreifuss muscular 
dystrophy (EDMD) myopathy(191). Although the molecular mechanisms underlying the 
pathological phenotype in such diseases remain the subject of intensive research, the 
observation of connections between nuclear lamina alternations and the disruption of 
chromatin organization(191) provide a promising platform for future studies. 
 
Understanding the principles of the regulated chromatin movements toward nuclear 
periphery is of a high importance, as it provides a new approach in developing novel 
therapeutic targets. Such reasoning is particularly relevant in reducing the pathological 
function of MYC by reducing its gating to the nuclear pore. Importantly, the gating of the 
MYC gene has so far been found to exist only in cancer cells. By antagonizing the gating 
process, we might be able to remove the driver of cancer evolution without adversely 
affecting the normal and important function of MYC in regenerating tissues and 








Paper I describes the novel finding that rhythmic chromatin repositioning between active 
and repressive nuclear compartments facilitates entrainment of circadian transcription. We 
could thus show that CTCF and PARP1 join forces to regulate the formation of the H19 
ICR chromatin network. This interactome is significantly enriched in inter-chromosomal 
interactions to connect active circadian loci with repressed LADs at nuclear periphery. 
Additionally, rhythmic recruitment of clock control genes to the nuclear lamina is 
facilitated by the entrainment by the serum shock, and it is followed by transcriptional 
attenuation mediated by the acquisition of repressive H3K9me2 mark in a time-dependent 
manner.  
 
Paper II demonstrates the dynamic and stochastic nature of the MYC chromatin network 
impinging on flanking enhancers, and its organization with MYC likely screening for 
neighboring interaction partners. This observation goes counter to the dogma that enhancer 
hubs simultaneously promote transcriptional activation. To find further evidence in favor of 
this conclusion, we modified the Nodewalk protocol to increase its sensitivity while 
retaining its ability to quantitatively determine frequencies of chromatin interactions. Our 
results show that MYC indeed seeks out enhancer regions one at a time to suggest the 
evolution of redundant mechanisms of MYC activation in cancer cells to increase their 
adaptability to a changing environment.    
 
Paper III identifies a single CTCF binding site within the oncogenic colorectal super-
enhancer to mediate increased levels of MYC expression in cancer cells. We also provide 
genetic evidence for that this OSE recruits MYC to the nuclear pores to thereby facilitate the 
nuclear export of MYC mRNAs. Moreover, we show that the mutation of the single, OSE-
specific CTCF-binding site abrogates the WNT-regulated MYC gating to identify a new 
target of this pivotal pathway. Additionally, we identified PARP1 as an essential partner of 






7 POINTS OF PERSPECTIVE 
 
Future research will attempt to further uncover the mechanisms and order of events regulating 
circadian chromatin movements between transcriptionally permissive and repressive nuclear 
sub-compartments and how these relate to the CTCF-PARP1 complex. Particularly 
interesting are mechanisms which cause the release of circadian loci from the nuclear 
periphery and the subsequent reversal of the repressive chromatin mark(s) when intra-
nucleoplasmic, as well as the link between CTCF-PARP1 and the core clock machinery. 
Additionally, further examination of principles underlying the novel principle of MYC gene 
gating in cancer cells might show how the cancer cells have exploited the clock machinery to 
hijack the gating process in order to increase their fitness. It will also be important to go 
beyond model systems and show these principles in action in patient materials. By 
extrapolation, it will be very interesting to examine to what extent circadian rhythm and gene 
gating are affected in laminopathies. In the end, the most important outcome of such 
endeavors will be to find new therapeutic strategies based on the dynamics of chromatin 
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The journey I had joined long time ago was the journey of my life, full of great moments, 
wonderful ideas and inspiring personalities. Someone said that time is precious so make 
sure you spend it with the right people. I feel very privileged and lucky that I had a chance 
to meet on my way wonderful people who really changed my life and made me grow. As 
we say in Poland, I would like to thank all of you and each one individually, especially: 
 
My supervisor, Associate Professor Anita Göndör, for all support you gave me during 
these years. From the first day I could count on your advice in both scientific and private 
manners. You put a lot of time and effort to make me grow as a scientist, sharing your ideas 
and experience with enormous patience. I was always truly amazed how broad knowledge 
you have and how can you find the answer for every question you get. And empathy you 
could share, especially during hard moments of my life. You made me truly fall in love in 
epigenetic which secrets I was discovering from the step zero with you. I got a lot of 
scientific opportunities and variety of different projects what made me feel interested and 
comfortable in different research fields. I still have a long way to go as a scientist but I will 
never forget the time I have a privilege to spend in your group. I wish you all best, and 
thank you once again for all good I got from you. 
 
Professor Rolf Ohlsson, for all the scientific advises I got from you. I am deeply amazed 
for the knowledge and passion for science you possess. You showed me what the real 
science means. You put a lot of effort to make me grow as a scientist, sharing your 
experience and ideas with me. Thank you for all suggestions I got from you. 
 
My co-supervisor professor Thomas Helleday, for all experience I gained during the time I 
spend in your group. You gave me a lot of scientific freedom and trust to run my own 
projects. Thank of that time I could learn how to efficiently plan and proceed with 
experimental work. I could collaborate with many bright scientists of different speciality 






Professor Galina Selivanova, for the mentorships during my PhD studies. It was always a 
great pleasure to talk to you, especially during our common working at MTC. 
 
I would like to warmly thank all of my lab friends, especially Marta Imreh for all support 
I got from you. You introduced me to the lab, was always ready to help and advice with the 
most silly scientific or administrative problems. You shared your great knowledge about the 
stem cell culture what honestly felt like a stepping into the highest scientific mysteries level 
for me. You helped me and all of us every day and your enormous job deserves a huge 
“Tack!”  
 
Jia Pei, thank you so much for all the discussions we had, especially for our breast cancer 
projects planning. You were always so kind and ready to help, I am deeply thankful for all 
support I got from you. You are always positive and have a great skill to keep a group 
together. I wish you all best! 
 
Mirco, I am really amazed how much passion and power you have. You make a lot of good 
to everyone around you and put a lot of effort to improve every KI student’s life. You are 
always ready to help, even in the middle of the night, sharing your experience and 
interesting scientific ideas. You give a lot of yourself to make it easy and safe for every one 
of us in the lab. I am sure you are going to have a bright future!  
 
Ilyas, thank you so much for all advices and discussions we have. It is visible how much 
you love science and how much knowledge you have. You were always ready to help me 
with my experiments, advice how to improve the results. Thank you for all your warm 
words and look forward to see you possessing the professor title! 
 
Johanna, you have enormous kindness in yourself. I was always impressed about your 
knowledge, even when you didn’t admit it. You are very modes but extremely bright 
person. Thank you for all the help I got from you, for all work you had done for every one 







Deeksha, it was so nice to talk to you when we had a chance to take lunch together here in 
Sweden! You are so positive and kind person, I am amazed how could you combine work 
with your private life! Thank you for all the support I got from you, patiently helping me to 
rise my -1 to 0 bioinformatics skills. I keep my fingers crossed for you! 
 
Carolina, thank you for all support I got from you. It was very nice to talk and work 
together during all these years. I will be always grateful for you help and experimental 
guidance, especially in the progeria project. I am very happy for all of you in your small 
family! Hug warmly Olivia from me! 
 
Barbara, you are really knowledgeable, experienced and exact scientist. I always admired 
how great working skills and habits you have, putting you as a my inner scientific goal I 
would like to reach someday. It was so nice to work with you and talk in privately hard 
moments. I wish you all best and I am sure you are going to get far! 
 
Ilias, you have a lot of passion for science. It was nice to discuss scientific problems with 
you both in the lab and during our group meetings. You had an inspiring journey and it was 
nice to get inspired from it as well. I wish you a bright future! 
 
Felipe, although we could work together for only a short period of time, you let me know 
you as patient, dedicated and knowledgeable person. I am sure you are going to take a good 
care of the breast cancer project, and any other research you are going to conduct. It was 
nice to talk about Brazil with you, and I hope I am going to come back there one day! 
 
Andrej, I really liked out “office neighbors” discussions. You have a broad knowledge and 
we could talk about many subjects, starting from science and finishing on politic. You are 
very positive and warm-heart person, and I wish you always stay that way! 
 
Shuangyang, I deeply admire how hard working you are. We set in the office till the long 
night hours, filling the breaks with discussions about the culture and music. You have very 






Rashid, I don’t think I have ever seen you in a bad mood! You are always positive, kind 
and helpful to everyone. I was always amazed when you start to discuss the programming 
mysteries and very thankful for all your work you had done for us to learn bioinformatics. I 
wish you best! 
 
Narsis, although we have never met in person, I really admired time we spent together 
during our online meetings. You are very positive, kind and bright-mind person, making a 
great science! I hope someday we could talk in real life and I will get a chance to learn from 
you even more!  
   
I would like to also thank to the former group members: Noriuki (I can’t find words to say 
how much I am amazed of your smartness, kindness and great sense of humor!), Alejandro 
(I still wait for Costa Rican cafe), Samer (when I see chocolate I still keep on smiling), 
Xingqui, (thank you for lab introduction), Chengxi (no one dance gangnam style better 
then you!), Honglei (thank you for all your help and support on our everyday fight to 
change the world!), Feri (thank you for all your help, support and time you gave me from 
the first day of my PhD journey <3!), Gozde (I loved the afternoon fun we had!), José (I 
still think yellow suited you), Luis (I really love your serenity and positive way of thinking 
- and that even after years you still help me with ISPLA…), Manos (I think you are the 
most cheerful person I know - even when for the tenth time I didn’t understand basics of 
bioinformatics…), Hao (it was so nice to work with you. I wish you all best!), Moumita (I 
will never thank you enough for help with fixing our Indian trip - without it I would 
probably still be somewhere in the desert), Maria (you always amazed my with things I 
have never heard about before!), Li-Sophie (I really enjoyed to make a mini renovation 
together with you!) . 
 
 
Professor Lars Holmgren for all support and positive energy I experienced form you. 
Thank you so much for the opportunity to work in CCK during the hard BioClinicum 
beginnings. You are really bright scientific mind and I really enjoyed your sense of 
humour! Yuanyouan, Vicky, Pedro, Evelyn, Aarren, Seema and all Holmgren’s team, 
you treated me as a group member and a friend letting me sharing a bench with you! I 





supportive and kind people, and bright scientists! I am very thankful that destiny let me 
know all of you, and I wish you all best in your private and scientific life! 
 
Professor Ingemar Ernberg, thank you for the MTC examination of the cancer biology 
knowledge. It was very nice to talk to you that time, and any other chance we got during 
my PhD carrier. You were always very positive, smart and supportive person.  
 
To all collaborators, co-authors and all scientific colleagues (also those whose work I 
didn’t reach/failed to cite in this thesis, I am very sorry for that) who scientifically 
contributed to make a human knowledge to progress!  
 
This journey wouldn’t start without the amazing people from Amgen Scholars Program. 
Being part of the Amgen family made me believe that impossible doesn’t exist, and that 
even the most unbelievable dreams can come true if you are lucky enough to meet someone 
who believe in you. And although you never admit - Jonas Sundbäck and Åsa Sjöman - a 
Swedish Amgen Scholars Program coordinators - I know that you played a big roll in 
letting me be 1/15 of the great team! Thank you so much for a chance I got, all your 
guidance and support you gave us during our ‘Karolinska Episode’ and introduction to the 
Swedish habits and cultures - that time I would never believe that I am going to use this 
knowledge in everyday life… Ania, Tomoki, Pijus, San, James, Angela, Olivia, Iva, 
Carmen, Olivera, Kate, Laura, Korbinian, Marta - you are one of the most incredible 
and brightest people I met! I got inspired by every one of you and for first time in my life 
felt that I am in the right place. I loved our all-night long discussions about science on the 
Jägargatan’s roof - we came here to change the world and nothing was impossible that 
time! 
I loved exploring Stockholm’s most interesting and weirdest places, our meetings in the 
kitchen followed by hours of fun and mostly - I loved to feel accepted, understood and 
wanted to be with! You probably don’t know how much you all changed my life! 
 
My Amgen experience wouldn’t be fulfilled without two amazing people I had a privilege 
to work with - Serhiy Souchelnytshyi and Olena Zakharchenko. Serhiy - thank you so 
much for all your guidance, help and belief you gave me. When I came to your lab I had 





wonder how could you hold your face without laughing while listen to all ideas of 
wonderful cancer therapies we have to immediately test. You gave me one of the most 
precious gifts student can get - your time and trust. Weighting 0.01g of ridiculously  
expensive TGF-beta inhibitor two weeks after I had barely learnt how to use the pipet 
became legendary - I still sweat thinking about it. And actually it was you Lena who 
thought me how to use the pipet - I think the most important and symbolic skill on the 
scientific journey. You stood all my stupid questions and even more stupid mistakes. But 
you gave me your guidance and trust which helped me to grow as a person and the 
scientist-to-be. Without your support and help I would never be able to reach impossible 
and get to the point I am now, and I would never meet Uffe! Thank you so much for taking 
me under your wings but most of all for you friendship. Я тепло обіймаю вас і вашу 
родину! Дякую тобі за все! 
 
I would like to also thank people who make my science experience really extraordinary - 
Helion Publishing House, MedPharm Publishing House, Khan Academy, Wiedza i 
Zycie Journal - you all made my voice heard and help me spread the beauty of science to 
hundreds of thousands of people. You let me talk about something I love, in the way love. 
Thank you for all your great work and support you gave me during our collaborations! 
 
All members of The Spokesmen of Science association, for letting me be a part of a great 
team! You all are really making an enormous job, bringing the science back to the society. 
Your engagement, passion and competence are inspiring. And upon all of that you are nice, 
friendly and helpful people sharing the same love as I possess - the love to discover 
undiscovered (and talking about it to anyone I meet…)! I keep my fingers crossed for all 
the future project and wish you all stay as positive as you are!    
 
I would like to also thank all my far away friends, which had been with me through all 
these years. Federica and Giacomo, although we met with you Federica only for a short 
time nearly ten years ago, you are still happily present in my life! I love to get to know 
about your life, I keep hardly fingers crossed for your future in Livorno and your other life-
plans! You are really smart person, I got so much inspired form you! Ola, Adam i Krzyś, 
for sharing all passion for science all these years. Olu, you know how much I admire you 





wish you all best! Kamil, Agnieszka and Kurt, we know each other for nearly 20 years 
soon (!) but from the day one I was really amazed of you Kamil. It was a great pleasure to 
know you and be your friend. We had so fun learning about the universe. It is funny how 
we drifted away from that interest! I wish you your family best, I keep fingers crossed so 
hardly for the future and can’t wait to meet you again (and I am so sorry for all grammar 
mistakes I had done in these five sentences…).  Michał, Agnieszka and Marcel for a 
friendship and all support during these years. I am very happy to see your small family 
together and very thankful for having you in my life. Michał, we had a great time at UWM, 
studying phytology and chemistry together! It was the time of my life. You made me 
believe, for first time in my life, that real friendship exists and I can really be a part of a 
great team. It was unforgettable experience and I am very happy we can still share it after 
years. I am very happy of you Agnieszka! You are extremely nice, smart and ambitious 
person. I am so happy for your parenthood and can't wait to meet small Marcel!  
 
And last but not least my dear family. Babci Ani, Babci Danusi, Dziadkowi Horstowi i 
Dziadkowi Jerzemu za wiarę i wsparcie w tej długiej drodze do celu. Wiem, że myślami 
byliście ze mną za co z całego serca Wam dziękuję. Pia, Jonas, Emilie, Elias och Elsa för 
att Ni är en del av min min familj här i Sverige. Ni är ett fantastiskt team och det värmer att 
se Er kärlek. Eva och Affe, för att Ni varit ett stort stöd från min första dag här i Sverige. 
Ni accepterade mig som Er dotter, vilket jag känt ända sedan vi först träffades. Jag är så 
tacksam för all hjälp jag fått med allt; från renovering till att ge goda råd vid bilköp! Jag 
önskar Er all hälsa och ser fram emot att dela många fler fantastiska stunder tillsammans 
med Er! Asi i Piotrkowi, za całe wsparcie i doping na tej długiej drodze do celu (i 
odbieranie tych wszystkich moich paczek!). Misiu, dziękuję Ci za długie, pełne śmiechu 
rozmowy na Fejsbusiu, w doli i niedoli. Zawsze byłaś dla mnie wsparciem, dopingowałaś, 
dbałaś o to, żebym miała jak najłatwiej w życiu. Dziękuję Ci za całą dobroć i wsparcie. 
Możesz już wyciągać kredki! Mamie i tacie za całą motywację to tego, aby dotrzeć tu, 
gdzie jestem. Musieliście podjąć wiele niełatwych decyzji w życiu, poświęciliście bardzo 
wiele abyśmy spełniały marzenia. Byliście ze mną w najtrudniejszych momentach, 
wspieraliście każde moje najdziwniejsze wybory i w końcu to wy kupiliście mi pierwszy 
mikroskop! Wasza wiara czyniła cuda, dziękuję Wam za każdy dzień i każdy uśmiech. 
Uffe, du är mitt livs kärlek, det har jag vetat sedan jag träffade dig första gången på tåg-





går. Du stod vid min sida i de svåraste ögonblicken, tog hand om mig, visade mig världen 
och vad ett riktigt partnerskap betyder. Vi har gått igenom mycket tufft; renovering, 
sjukdomar, dödsfallar men vi gjorde det tillsammans och lyckades få livet att kännas 
fantastiskt! Du är min bästa vän och jag älskar dig! Förutom ditt tålamod, dina råd, din 
vänlighet och härliga humor gav Du mig det som är mest värdefullt i mitt liv: Daniel och 
David. Jag visste inte att man kan älska någon så mycket förrän jag träffade Er. Ni är 
meningen med mitt liv och fyller varje dag med glädje och lycka. Jag är stolt över Er men 
mest tacksam för att jag kunde vara med så fantastiska, hjärtliga, snälla och ljusa 
personligheter. Jag lär av Er varje dag och blir förvånad över hur mycket passion Ni har. 
Mitt viktigaste mål och livsdröm är att Ni ska vara lyckliga i Era liv. Jestem i zawsze będę z 


















9   REFERENCES 
1.  Flavahan WA, Gaskell E, Bernstein BE. Epigenetic plasticity and the hallmarks of 
cancer. Vol. 357, Science. American Association for the Advancement of Science; 
2017.  
2.  Allis CD, Jenuwein T. The molecular hallmarks of epigenetic control. Nat Rev Genet 
[Internet]. 2016;17(8):487–500. Available from: http://dx.doi.org/10.1038/nrg.2016.59 
3.  Raj A, Oudenaarden A van. Stochastic gene expression and its consequences. Cell 2. 
2008;135(2):216–26.  
4.  Han R, Huang G, Wang Y, Xu Y, Hu Y, Jiang W, et al. Increased gene expression 
noise in human cancers is correlated with low p53 and immune activities as well as 
late stage cancer. Oncotarget. 2016;7(44):72011–20.  
5.  Cavalli G, Heard E. Advances in epigenetics link genetics to the environment and 
disease. Nature [Internet]. 2019;571(7766):489–99. Available from: 
http://dx.doi.org/10.1038/s41586-019-1411-0 
6.  Göndör A. Chromatin Regulation and Dynamics. Vol. 11, London, Elsevier, 
Academic Press. 2017.  
7.  Göndör A, Ohlsson R. Chromosome crosstalk in three dimensions. Nature. 
2009;461(7261):212–7.  
8.  Luger K, Dechassa ML, Tremethick DJ. New insights into nucleosome and chromatin 
structure: An ordered state or a disordered affair? Nat Rev Mol Cell Biol. 
2012;13(7):436–47.  
9.  Bowman GD, Poirier MG. Post-translational modifications of histones that influence 
nucleosome dynamics. Chem Rev. 2015;115(6):2274–95.  
10.  Tang F, Yang Z, Tan Y, Li Y. Super-enhancer function and its application in cancer 
targeted therapy. npj Precis Oncol [Internet]. 2020;4(1):1–7. Available from: 
http://dx.doi.org/10.1038/s41698-020-0108-z 
11.  Pott S, Lieb JD. What are super-enhancers? Vol. 47, Nature Genetics. Nature 
Publishing Group; 2015. p. 8–12.  
12.  Mannervik M, Nibu Y, Zhang H, Levine M. Transcriptional Coregulators in 
Development. Science (80- ). 1999;284(April):606–10.  
13.  Holmqvist P, Mannervik M. Genomic occupancy of the transcriptional co- activators 
p300 and CBP. Transcription. 2013;1264(4:1):18–23.  
14.  Nguyen MLT, Jones SA, Prier JE, Russ BE. Transcriptional enhancers in the 
regulation of T cell differentiation. Front Immunol. 2015;6(SEP).  
15.  Heinz S, Romanoski CE, Benner C, Glass CK. The selection and function of cell type-
specific enhancers. Nat Rev Mol Cell Biol. 2015;16(3):144–54.  
16.  Atlasi Y, Stunnenberg HG. The interplay of epigenetic marks during stem cell 





Available from: http://dx.doi.org/10.1038/nrg.2017.57 
17.  Göndör A, Ohlsson R. Enhancer functions in three dimensions: Beyond the flat world 
perspective [version 1; referees: 3 approved]. F1000Research. 2018;7(May):1–11.  
18.  Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-André V, Sigova AA, et al. Super-
enhancers in the control of cell identity and disease. Cell. 2013 Nov 7;155(4):934.  
19.  The ENCODE Project Consortium. An integrated encyclopedia of DNA elements in 
the human genome. Nature. 2012;489(7414):57–74.  
20.  Ko JY, Oh S, Yoo KH. Functional enhancers as master regulators of Tissue-Specific 
gene regulation and cancer development. Mol Cells. 2017;40(3):169–77.  
21.  Wang X, Cairns MJ, Yan J. Super-enhancers in transcriptional regulation and genome 
organization. Vol. 47, Nucleic Acids Research. Oxford University Press; 2019. p. 
11481–96.  
22.  Whyte WA, Orlando DA, Hnisz D, Abraham BJ, Lin CY, Kagey MH, et al. Master 
transcription factors and mediator establish super-enhancers at key cell identity genes. 
Cell [Internet]. 2013;153(2):307–19. Available from: 
http://dx.doi.org/10.1016/j.cell.2013.03.035 
23.  Jia Q, Chen S, Tan Y, Li Y, Tang F. Oncogenic super-enhancer formation in 
tumorigenesis and its molecular mechanisms. Exp Mol Med [Internet]. 
2020;52(5):713–23. Available from: http://dx.doi.org/10.1038/s12276-020-0428-7 
24.  Mora A, Sandve GK, Gabrielsen OS, Eskeland R. In the loop: promoter-enhancer 
interactions and bioinformatics. Brief Bioinform. 2016;17(6):980–95.  
25.  Snetkova V, Skok JA. Enhancer talk. Epigenomics. 2018;10(4):483–98.  
26.  Kagey MH, Newman JJ, Bilodeau S, Zhan Y, Orlando DA, Van Berkum NL, et al. 
Mediator and cohesin connect gene expression and chromatin architecture. Nature. 
2010;467(7314):430–5.  
27.  Huang J, Li K, Cai W, Liu X, Zhang Y, Orkin SH, et al. Dissecting super-enhancer 
hierarchy based on chromatin interactions. Nat Commun. 2018 Dec 1;9(1).  
28.  Rudebeck SR, Bor D, Ormond A, O’Reilly JX, Lee ACH. A Potential Spatial Working 
Memory Training Task to Improve Both Episodic Memory and Fluid Intelligence. 
PLoS One. 2012;7(11):1–9.  
29.  Matharu N, Ahituv N. Minor Loops in Major Folds: Enhancer–Promoter Looping, 
Chromatin Restructuring, and Their Association with Transcriptional Regulation and 
Disease. PLoS Genet. 2015;11(12):1–14.  
30.  Tokuda N, Sasai M, Chikenji G. Roles of DNA looping in enhancer-blocking activity. 
Biophys J [Internet]. 2011;100(1):126–34. Available from: 
http://dx.doi.org/10.1016/j.bpj.2010.11.016 
31.  Willi M, Yoo KH, Reinisch F, Kuhns TM, Lee HK, Wang C, et al. Facultative CTCF 
sites moderate mammary superenhancer activity and regulate juxtaposed gene in non-






32.  Maksimenko OG, Chetverina DA, Georgiev PG. Insulators of higher eukaryotes: 
Properties, mechanisms of action, and role in transcriptional regulation. Russ J Genet. 
2006;42(8):845–57.  
33.  Yoon YS, Jeong S, Rong Q, Park K-Y, Chung JH, Pfeifer K. Analysis of the H19ICR 
Insulator. Mol Cell Biol. 2007;27(9):3499–510.  
34.  Kurukuti S, Tiwari VK, Tavoosidana G, Pugacheva E, Murrell A, Zhao Z, et al. CTCF 
binding at the H19 imprinting control region mediates maternally inherited higher-
order chromatin conformation to restrict enhancer access to Igf2. Proc Natl Acad Sci U 
S A. 2006;103(28):10684–9.  
35.  Chen Y, Dhupelia A, Schoenherr CJ. The Igf2/H19 imprinting control region exhibits 
sequence-specific and cell-type-dependent DNA methylation-mediated repression. 
Nucleic Acids Res. 2009;37(3):793–803.  
36.  Banerjee S, Smallwood A, Lamond S, Campbell S, Nargund G. Igf2/H19 imprinting 
control region (ICR): an insulator or a position-dependent silencer? 
ScientificWorldJournal. 2001;1:218–24.  
37.  Kim S, Yu NK, Kaang BK. CTCF as a multifunctional protein in genome regulation 
and gene expression. Exp Mol Med. 2015;47(February):e166.  
38.  Zhao Z, Tavoosidana G, Sjölinder M, Göndör A, Mariano P, Wang S, et al. Circular 
chromosome conformation capture (4C) uncovers extensive networks of epigenetically 
regulated intra- and interchromosomal interactions. Nat Genet. 2006;38(11):1341–7.  
39.  Cavalli G, Misteli T. Functional implications of genome topology. Nat Struct Mol 
Biol. 2013;20(3):290–9.  
40.  Bouwman BAM, De Laat W. Architectural hallmarks of the pluripotent genome. 
FEBS Lett [Internet]. 2015;589(20):2905–13. Available from: 
http://dx.doi.org/10.1016/j.febslet.2015.04.055 
41.  Fortin JP, Hansen KD. Reconstructing A/B compartments as revealed by Hi-C using 
long-range correlations in epigenetic data. Genome Biol. 2015;16(1):1–23.  
42.  Rao SSP, Huntley MH, Durand NC, Stamenova EK, Bochkov ID, Robinson JT, et al. 
A 3D map of the human genome at kilobase resolution reveals principles of chromatin 
looping. Cell [Internet]. 2014;159(7):1665–80. Available from: 
http://dx.doi.org/10.1016/j.cell.2014.11.021 
43.  Lazaris C, Aifantis I, Tsirigos A. On Epigenetic Plasticity and Genome Topology. 
Trends in Cancer [Internet]. 2020;6(3):177–80. Available from: 
https://doi.org/10.1016/j.trecan.2020.01.006 
44.  Gómez-Díaz E, Corces VG. Architectural proteins: Regulators of 3D genome 
organization in cell fate. Trends Cell Biol. 2014;24(11):703–11.  
45.  Madakashira BP, Sadler KC. DNA methylation, nuclear organization, and cancer. 





46.  Lochs SJA, Kefalopoulou S, Kind J. Lamina Associated Domains and Gene 
Regulation in Development and Cancer. Cells. 2019;8(3):271.  
47.  Ong C-T, Corces VG. CTCF: an architectural protein bridging genome topology and 
function. Nat Rev Genet [Internet]. 2014 Apr [cited 2014 Jul 10];15(4):234–46. 
Available from: http://www.ncbi.nlm.nih.gov/pubmed/24614316 
48.  van Steense B, Belmont S. A. Lamina-associated domains: links with chromosome 
architecture, heterochromatin and gene repression. Cell. 2017;169(5):780–91.  
49.  Wen B, Wu H, Shinkai Y, Irizarry RA, Feinberg AP. Large histone H3 lysine 9 
dimethylated chromatin blocks distinguish differentiated from embryonic stem cells. 
Nat Genet. 2009;41(2):246–50.  
50.  Bolzer A, Kreth G, Solovei I, Koehler D, Saracoglu K, Fauth C, et al. Three-
dimensional maps of all chromosomes in human male fibroblast nuclei and 
prometaphase rosettes. PLoS Biol. 2005;3(5):0826–42.  
51.  Lanctôt C, Cheutin T, Cremer M, Cavalli G, Cremer T. Dynamic genome architecture 
in the nuclear space: Regulation of gene expression in three dimensions. Nat Rev 
Genet. 2007;8(2):104–15.  
52.  Marshall WF, Straight A, Marko JF, Swedlow J, Dernburg A, Belmont A, et al. 
Interphase chromosomes undergo constrained diffusional motion in living cells. Curr 
Biol. 1997;7(12):930–9.  
53.  Finlan LE, Sproul D, Thomson I, Boyle S, Kerr E, Perry P, et al. Recruitment to the 
nuclear periphery can alter expression of genes in human cells. PLoS Genet. 
2008;4(3).  
54.  Soutoglou E, Misteli T. Mobility and immobility of chromatin in transcription and 
genome stability. Curr Opin Genet Dev. 2007;17(5):435–42.  
55.  Blobel G. Gene gating: A hypothesis. Proc Natl Acad Sci U S A. 1985;82(24):8527–9.  
56.  Scholz BA, Sumida N, de Lima CDM, Chachoua I, Martino M, Tzelepis I, et al. WNT 
signaling and AHCTF1 promote oncogenic MYC expression through super-enhancer-
mediated gene gating. Nat Genet [Internet]. 2019;51(12):1723–31. Available from: 
http://dx.doi.org/10.1038/s41588-019-0535-3 
57.  Burns LT, Wente SR. From Hypothesis to Mechanism: Uncovering Nuclear Pore 
Complex Links to Gene Expression. Mol Cell Biol. 2014;34(12):2114–20.  
58.  Chuang CH, Carpenter AE, Fuchsova B, Johnson T, de Lanerolle P, Belmont AS. 
Long-Range Directional Movement of an Interphase Chromosome Site. Curr Biol. 
2006;16(8):825–31.  
59.  Gordon MR, Pope BD, Sima J, Gilbert DM. Many paths lead chromatin to the nuclear 
periphery. BioEssays. 2015;37(8):862–6.  
60.  Misteli T. Concepts in nuclear architecture. BioEssays 275 [Internet]. 2005;27:477–87. 
Available from: http://www.cs.bham.ac.uk/~jxb/NN/l16.pdf 





and Its Consequences. Cell. 2008;135(2):216–26.  
62.  Müller HP, Sogo JM, Schaffner W. An enhancer stimulates transcription in Trans 
when attached to the promoter via a protein bridge. Cell. 1989;58(4):767–77.  
63.  Rieder D, Trajanoski Z, McNally JG. Transcription factories. Front Genet. 
2012;3(OCT):1–12.  
64.  Lenchenko A, Nemenman I. Cellular noise and information transmission. Curr Opin 
Biotechnol. 2014;August(28):156–64.  
65.  Ohlsson R. Widespread Monoallelic Expression. Science (80- ). 
2007;318(November):1077–8.  
66.  Arzate-Mejía RG, Recillas-Targa F, Corces VG. Developing in 3D: the role of CTCF 
in cell differentiation. Development. 2018;145(6).  
67.  Ohlsson R, Renkawitz R, Lobanenkov V. CTCF is a uniquely versatile transcription 
regulator linked to epigenetics and disease. Trends Genet. 2001;17(9):520–7.  
68.  Ohlsson R, Lobanenkov V, Klenova E. Does CTCF mediate between nuclear 
organization and gene expression? BioEssays. 2010;32:37–50.  
69.  Lobanenkov V V., Nicolas RH, Adler V V., Paterson H, Klenova EM, Polotskaja A 
V., et al. A novel sequence-specific DNA binding protein which interacts with three 
regularly spaced direct repeats of the CCCTC-motif in the 5’-flanking sequence of the 
chicken c-myc gene. Oncogene. 1990;5(12):1743–53.  
70.  Pant V, Kurukuti S, Pugacheva E, Shamsuddin S, Mariano P, Renkawitz R, et al. 
Mutation of a Single CTCF Target Site within the H19 Imprinting Control Region 
Leads to Loss of Igf2 Imprinting and Complex Patterns of De Novo Methylation upon 
Maternal Inheritance. Mol Cell Biol. 2004;24(8):3497–504.  
71.  Guibert S, Zhao Z, Sjölinder M, Göndör A, Fernandez A, Pant V, et al. CTCF-binding 
sites within the H19 ICR differentially regulate local chromatin structures and cis-
acting functions. Epigenetics. 2012;7(4):361–9.  
72.  Kanduri C, Pant V, Loukinov D, Pugacheva E, Qi CF, Wolffe A, et al. Functional 
association of CTCF with the insulator upstream of the H19 gene is parent of origin-
specific and methylation-sensitive. Curr Biol. 2000;10(14):853–6.  
73.  Marina RJ, Sturgill D, Bailly MA, Thenoz M, Varma G, Prigge MF, et al. TET-
catalyzed oxidation of intragenic alternative splicing. EMBO J. 2016;35(3):335–55.  
74.  Han D, Chen Q, Shi J, Zhang F, Yu X. CTCF participates in DNA damage response 
via poly(ADP-ribosyl)ation. Sci Rep. 2017;7(January):1–10.  
75.  Hu J, Zhang Y, Zhao L, Frock RL, Du Z, Meyers RM, et al. Chromosomal Loop 
Domains Direct the Recombination of Antigen Receptor Genes. Cell. 
2015;163(4):947–59.  
76.  Zuin J, Dixon JR, Van Der Reijden MIJA, Ye Z, Kolovos P, Brouwer RWW, et al. 
Cohesin and CTCF differentially affect chromatin architecture and gene expression in 





77.  Hansen AS, Pustova I, Cattoglio C, Tjian R, Darzacq X. CTCF and cohesin regulate 
chromatin loop stability with distinct dynamics. Elife. 2017;6:1–33.  
78.  Pugacheva EM, Kubo N, Loukinov D, Tajmul M, Kang S, Kovalchuk AL, et al. CTCF 
mediates chromatin looping via N-terminal domain-dependent cohesin retention. Proc 
Natl Acad Sci U S A. 2020;117(4):2020–31.  
79.  Ohlsson R, Bartkuhn M, Renkawitz R. CTCF shapes chromatin by multiple 
mechanisms: The impact of 20 years of CTCF research on understanding the workings 
of chromatin. Chromosoma. 2010;119(4):351–60.  
80.  Göndör A, Ohlsson R. Chromatin insulators and cohesins. EMBO Rep. 
2008;9(4):327–9.  
81.  Dorsett D, Ström L. The Ancient and Evolving Roles of Cohesin in Gene Expression 
and DNA Repair. Curr Biol 22. 2012;April 20:R240–50.  
82.  Ciccarone F, Zampieri M, Caiafa P. PARP1 orchestrates epigenetic events setting up 
chromatin domains. Semin Cell Dev Biol [Internet]. 2017;63:123–34. Available from: 
http://dx.doi.org/10.1016/j.semcdb.2016.11.010 
83.  Benabdallah NS, Williamson I, Illingworth RS, Boyle S, Grimes GR, Therizols P, et 
al. PARP mediated chromatin unfolding is coupled to long-range enhancer activation. 
bioRxiv. 2017;  
84.  Lupey-Green LN, Caruso LB, Madzo J, Martin KA, Tan Y, Hulse M, et al. PARP1 
Stabilizes CTCF Binding and Chromatin Structure To Maintain Epstein-Barr Virus 
Latency Type. J Virol. 2018;92(18):1–15.  
85.  Pavlaki I, Docquier F, Chernukhin I, Kita G, Gretton S, Clarkson CT, et al. Poly(ADP-
ribosyl)ation associated changes in CTCF-chromatin binding and gene expression in 
breast cells. bioRxiv. 2017;44(0):1–26.  
86.  Farrar D, Rai S, Chernukhin I, Jagodic M, Ito Y, Yammine S, et al. Mutational 
Analysis of the Poly(ADP-Ribosyl)ation Sites of the Transcription Factor CTCF 
Provides an Insight into the Mechanism of Its Regulation by Poly(ADP-Ribosyl)ation. 
Mol Cell Biol. 2010;30(5):1199–216.  
87.  Yu W, Ginjala V, Pant V, Chernukhin I, Whitehead J, Docquier F, et al. Poly(ADP-
ribosyl)ation regulates CTCF-dependent chromatin insulation. Nat Genet. 
2004;36(10):1105–10.  
88.  Klenova E, Ohlsson R. Poly(ADP-ribosyl)ation and epigenetics: Is CTCF PARt of the 
plot? Cell Cycle. 2005;4(1):96–101.  
89.  de Wit E, de Laat W. A decade of 3C technologies: Insights into nuclear organization. 
Genes Dev. 2012;26(1):11–24.  
90.  Dekker J, Rippe K, Dekker M, Kleckner N. Capturing chromosome conformation. 
Methods Mol Biol. 2002;295(15 February):1306–11.  
91.  Sati S, Cavalli G. Chromosome conformation capture technologies and their impact in 
understanding genome function. Chromosoma [Internet]. 2017;126(1):33–44. 





92.  Dekker J, Marti-Renom MA, Mirny LA. Exploring the three-dimensional organization 
of genomes: Interpreting chromatin interaction data. Nat Rev Genet. 2013;14(6):390–
403.  
93.  Göndör A, Rougier C, Ohlsson R. High-resolution circular chromosome conformation 
capture assay. Nat Protoc. 2008;3(2):303–13.  
94.  Ohlsson R, Göndör A. The 4C technique: the “Rosetta stone” for genome biology in 
3D? Curr Opin Cell Biol. 2007;19(3):321–5.  
95.  Dostie J, Richmond TA, Arnaout RA, Selzer RR, Lee WL, Honan TA, et al. 
Chromosome Conformation Capture Carbon Copy (5C): A massively parallel solution 
for mapping interactions between genomic elements. Genome Res. 2006;16(10):1299–
309.  
96.  Lieberman-Aiden E, van Berkum NL, Williams L, Imakaev M, Ragoczy T, Telling A, 
et al. Comprehensive mapping of long range interactions reveals folding principles of 
the human genome. Science (80- ). 2009;326(5950):289–93.  
97.  Risca VI, Greenleaf WJ. Unraveling the 3D genome: Genomics tools for multiscale 
exploration. Trends Genet [Internet]. 2015;31(7):357–72. Available from: 
http://dx.doi.org/10.1016/j.tig.2015.03.010 
98.  Nagano T, Lubling Y, Stevens TJ, Schoenfelder S, Yaffe E, Dean W, et al. Single-cell 
Hi-C reveals cell-to-cell variability in chromosome structure. Nature. 
2013;502(7469):59–64.  
99.  Chen X, Shi C, Yammine S, Göndör A, Rönnlund D, Fernandez-Woodbridge A, et al. 
Chromatin in situ proximity (ChrISP): Single-cell analysis of chromatin proximities at 
a high resolution. Biotechniques. 2014;56(3):117–24.  
100.  Chen X, Yammine S, Shi C, Tark-Dame M, Göndör A, Ohlsson R. The visualization 
of large organized chromatin domains enriched in the H3K9me2 mark within a single 
chromosome in a single cell. Epigenetics. 2014;9(11):1439–45.  
101.  Sumida N, Sifakis EG, Scholz BA, Fernandez-Woodbridge A, Kiani NA, Gomez-
Cabrero D, et al. The ultra-sensitive Nodewalk technique identifies stochastic from 
virtual, population-based enhancer hubs regulating MYC in 3D: Implications for the 
fitness of cancer cells. bioRxiv. 2018;  
102.  Bellet MM, Sassone-Corsi P. Mammalian circadian clock and metabolism - The 
epigenetic link. J Cell Sci. 2010;123:3837–48.  
103.  Andreani TS, Itoh TQ, Yildirim E, Hwangbo D-S, Allada R. Genetics of Circadian 
Rhythms. Sleep Med Clin. 2015;10(4):413–21.  
104.  Dibner C, Schibler U, Albrecht U. The mammalian circadian timing system: 
Organization and coordination of central and peripheral clocks. Vol. 72, Annual 
Review of Physiology. 2009. 517–549 p.  
105.  Yoo SH, Yamazaki S, Lowrey PL, Shimomura K, Ko CH, Buhr ED, et al. 
PERIOD2::LUCIFERASE real-time reporting of circadian dynamics reveals persistent 






106.  Ye R, Selby CP, Chiou YY, Ozkan-Dagliyan I, Gaddameedhi S, Sancar A. Dual 
modes of CLOCK:BMAL1 inhibition mediated by Cryptochrome and period proteins 
in the mammalian circadian clock. Genes Dev. 2014;28(18):1989–98.  
107.  Xie Y, Tang Q, Chen G, Xie M, Yu S, Zhao J, et al. New insights into the circadian 
rhythm and its related diseases. Front Physiol. 2019;10(JUN):1–19.  
108.  Dierickx P, Laake LW Van, Geijsen N. Circadian clocks : from stem cells to tissue 
homeostasis and regeneration. EMBO Rep. 2017;1–11.  
109.  Golombek DA, Rosenstein RE. Physiology of circadian entrainment. Physiol Rev. 
2010;90(3):1063–102.  
110.  Mohawk JA, Green CB, Takahashi JS. Central and peripheral circadian clocks in 
mammals. Annu Rev Neurosci. 2012;35:445–62.  
111.  Stephan FK, Swann JM, Sisk CL. Entrainment of circadian rhythms by feeding 
schedules in rats with suprachiasmatic lesions. Behav Neural Biol. 1979;25(4):545–54.  
112.  Lamia KA, Sachdeva UM, Di Tacchio L, Williams EC, Alvarez JG, Egan DF, et al. 
AMPK regulates the circadian clock by cryptochrome phosphorylation and 
degradation. Science (80- ). 2009;326(5951):437–40.  
113.  Hirota T, Okano T, Kokame K, Shirotani-Ikejima H, Miyata T, Fukada Y. Glucose 
down-regulates Per1 and Per2 mRNA levels and induces circadian gene expression in 
cultured rat-1 fibroblasts. J Biol Chem. 2002;277(46):44244–51.  
114.  Mistlberger RE, Skene DJ. Social influences on mammalian circadian rhythms: 
Animal and human studies. Biol Rev Camb Philos Soc. 2004;79(3):533–56.  
115.  Balsalobre  a, Damiola F, Schibler U. A serum shock induces circadian gene 
expression in mammalian tissue culture cells. Cell [Internet]. 1998 Jun 12;93(6):929–
37. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9635423 
116.  Balsalobre A, Marcacci L, Schibler U. Multiple signaling pathways elicit circadian 
gene expression in cultured Rat-1 fibroblasts. Curr Biol. 2000;10(20):1291–4.  
117.  Yagita K, Okamura H. Forskolin induces circadian gene expression of rPer1, rPer2 
and dbp in mammalian rat-1 fibroblasts. FEBS Lett. 2000;465(1):79–82.  
118.  Levi F, Schibler U. Circadian Rhythms: Mechanisms and Therapeutic Implications. 
Annu Rev Pharmacol Toxicol. 2007;47:593–628.  
119.  Gachon F, Nagoshi E, Brown SA, Ripperger J, Schibler U. The mammalian circadian 
timing sytem: From gene expression to physiology. Chromosoma. 2004;113(3):103–
12.  
120.  Harmer SL, Hogenesch JB, Straume M, Chang HS, Han B, Zhu T, et al. Orchestrated 
transcription of key pathways in Arabidopsis by the circadian clock. Science (80- ). 
2000;290(5499):2110–3.  





Segregation of nitrogen fixation and oxygenic photosynthesis in the marine 
cyanobacterium Trichodesmium. Science (80- ). 2001;294(5546):1534–7.  
122.  Weger M, Diotel N, Dorsemans A-C, Dickmeis T, Weger BD. Stem cells and the 
circadian clock. Dev Biol. 2017;431:111–23.  
123.  Janich P, Toufighi K, Solanas G, Luis NM, Minkwitz S, Serrano L, et al. Human 
epidermal stem cell function is regulated by circadian oscillations. Cell Stem Cell 
[Internet]. 2013;13(6):745–53. Available from: 
http://dx.doi.org/10.1016/j.stem.2013.09.004 
124.  Janich P, Pascual G, Merlos-Suarez A, Batlle E, Ripperger JA, Albrecht U, et al. The 
circadian molecular clock creates epidermal stem cell heterogeneity. Nature. 
2011;480(8 December):209–16.  
125.  Brown SA. Circadian clock-mediated control of stem cell division and differentiation: 
beyond night and day. Co Biol Ltd. 2014;141:3105–11.  
126.  Kang TH, Reardon JT, Kemp M, Sancar A. Orcadian oscillation of nucleotide excision 
repair in mammalian brain. Proc Natl Acad Sci U S A. 2009;106(8):2864–7.  
127.  Brainard J, Gobel M, Scott B, Koeppen M, Eckle T. Health implications of disrupted 
circadian rhythms and the potential for daylight as therapy. Anesthesiology. 
2015;122(5):1170–5.  
128.  Crosio C, Cermakian N, Allis CD, Sassone-Corsi P. Light induces chromatin 
modification in cells of the mammalian circadian clock. Nat Neurosci. 
2000;3(12):1241–7.  
129.  Aguilar-Arnal L, Sassone-Corsi P. Chromatin landscape and circadian dynamics: 
Spatial and temporal organization of clock transcription. Proc Natl Acad Sci U S A. 
2015;112(22):6863–70.  
130.  Koike N, Yoo SH, Huang HC, Kumar V, Lee C, Kim TK, et al. Transcriptional 
architecture and chromatin landscape of the core circadian clock in mammals. Science 
(80- ). 2012;338(6105):349–54.  
131.  Pacheco-Bernal I, Becerril-Pérez F, Aguilar-Arnal L. Circadian rhythms in the three-
dimensional genome: Implications of chromatin interactions for cyclic transcription. 
Clin Epigenetics. 2019;11(1):1–13.  
132.  Zhu Q, Belden WJ. Molecular Regulation of Circadian Chromatin. J Mol Biol 
[Internet]. 2020;432(12):3466–82. Available from: 
https://doi.org/10.1016/j.jmb.2020.01.009 
133.  Partch CL, Green CB, Takahashi JS. Molecular Architecture of the Mammalian 
Circadian Clock. Trends Cell Biol. 2014;24(2):90–9.  
134.  Feinberg AP, Koldobskiy MA, Göndör A. Epigenetic modulators, modifiers and 
mediators in cancer aetiology and progression. Nat Rev Genet. 2016;17(5):284–99.  
135.  Salvador ML, Klein U, Bogorad L. Endogenous Fluctuations of DNA Topology in the 





136.  Ripperger JA, Schibler U. Rhythmic CLOCK-BMAL1 binding to multiple E-box 
motifs drives circadian Dbp transcription and chromatin transitions. Nat Genet. 
2006;38(3):369–74.  
137.  Aguilar-Arnal L, Hakim O, Patel VR, Baldi P, Hager GL, Sassone-Corsi P. Cycles in 
spatial and temporal chromosomal organization driven by the circadian clock. Nat 
Struct Mol Biol. 2013;20(10):1206–15.  
138.  Devalaraja-Narashimha K, Padanilam BJ. PARP1 deficiency exacerbates diet-induced 
obesity in mice. J Endocrinol. 2010;205(3):243–52.  
139.  Vida A, Márton J, Mikó E, Bai P. Metabolic roles of poly(ADP-ribose) polymerases. 
Semin Cell Dev Biol [Internet]. 2017;63:135–43. Available from: 
http://dx.doi.org/10.1016/j.semcdb.2016.12.009 
140.  Kumar V, Takahashi JS. PARP around the Clock. Cell. 2010;142(17):841–3.  
141.  Asher G, Reinke H, Altmeyer M, Gutierrez-Arcelus M, Hottiger MO, Schibler U. 
Poly(ADP-Ribose) Polymerase 1 Participates in the Phase Entrainment of Circadian 
Clocks to Feeding. Cell [Internet]. 2010;142(6):943–53. Available from: 
http://dx.doi.org/10.1016/j.cell.2010.08.016 
142.  Trott AJ, Menet JS. Regulation of circadian clock transcriptional output by 
CLOCK:BMAL1. Vol. 14, PLoS Genetics. 2018. 1–34 p.  
143.  Zhao H, Sifakis EG, Sumida N, Millán-Ariño L, Scholz BA, Svensson JP, et al. 
PARP1- and CTCF-Mediated Interactions between Active and Repressed Chromatin 
at the Lamina Promote Oscillating Transcription. Mol Cell. 2015;59(6):984–97.  
144.  Ha NH, Long J, Cai Q, Shu XO, Hunter KW. The Circadian Rhythm Gene Arntl2 Is a 
Metastasis Susceptibility Gene for Estrogen Receptor-Negative Breast Cancer. PLoS 
Genet. 2016;12(9):1–20.  
145.  Feng CM, Qiu Y, Van Buskirk EK, Yang EJ, Chen M. Light-regulated gene 
repositioning in Arabidopsis. Nat Commun. 2014;5:3027.  
146.  Weidemann BJ, Ramsey KM, Bass J. A day in the life of chromatin: How enhancer–
promoter loops shape daily behavior. Genes Dev. 2018;32(5–6):321–3.  
147.  Kim YH, Marhon SA, Zhang Y, Steger DJ, Won KJ, Lazar MA. Rev-erba 
dynamically modulates chromatin looping to control circadian gene transcription. 
Science (80- ). 2018;359(6381):1274–7.  
148.  Mermet J, Yeung J, Hurni C, Mauvoisin D, Gustafson K, Jouffe C, et al. Clock-
dependent chromatin topology modulates circadian transcription and behavior. Genes 
Dev. 2018;32(5–6):347–58.  
149.  Diettrich Mallet de Lima C, Göndör A. Circadian organization of the genome. Science 
(80- ). 2018;359(March 16):1212–3.  
150.  Kelleher FC, Rao A, Maguire A. Circadian molecular clocks and cancer. Cancer Lett 






151.  Imreh MP, Wolbank S, Unger C, Gertow K, Aints A, Szeles A, et al. Culture and 
expansion of the human embryonic stem cell line HS181, evaluated in a double-color 
system. Stem Cells Dev. 2004;13(4):337–43.  
152.  Söderberg O, Gullberg M, Jarvius M, Ridderstråle K, Leuchowius KJ, Jarvius J, et al. 
Direct observation of individual endogenous protein complexes in situ by proximity 
ligation. Nat Methods. 2006;3(12):995–1000.  
153.  Chen X, Shi C, Yammine S, Göndör A, Rönnlund D, Fernandez-Woodbridge A, et al. 
Chromatin in situ proximity (ChrISP): Single-cell analysis of chromatin proximities at 
a high resolution. Biotechniques. 2014;56(3):117–24.  
154.  Sumida N, Sifakis E, Scholz B, Fernandez-Woodbridge A, Kiani N, Gomez-Cabrero 
D, et al. The ultra-sensitive Nodewalk technique identifies stochastic from virtual, 
population-based enhancer hubs regulating MYC in 3D: Implications for the fitness of 
cancer cells. bioRxiv. 2018;286583.  
155.  Pant V, Mariano P, Kanduri C, Mattsson A, Lobanenkov V, Heuchel R, et al. The 
nucleotides responsible for the direct physical contact between the chromatin insulator 
protein CTCF and the H19 imprinting control region manifest parent of origin-specific 
long-distance insulation and methylation-free domains. Genes Dev. 2003;17(5):586–
90.  
156.  Sandhu KS, Shi C, Sjölinder M, Zhao Z, Göndör A, Liu L, et al. Nonallelic 
transvection of multiple imprinted loci is organized by the H19 imprinting control 
region during germline development. Genes Dev. 2009;23(22):2598–603.  
157.  Bickmore W a, van Steensel B. Genome architecture: domain organization of 
interphase chromosomes. Cell [Internet]. 2013 Mar 14 [cited 2014 Jul 
15];152(6):1270–84. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23498936 
158.  Zlatanova J, Caiafa P. CTCF and its protein partners: Divide and rule? J Cell Sci. 
2009;122(9):1275–84.  
159.  Brochu G, Duchaine C, Thibeault L, Lagueux J, Shah GM, Poirier GG. Mode of 
action of poly(ADP-ribose) glycohydrolase. BBA - Gene Struct Expr. 
1994;1219(2):342–50.  
160.  Bochum S, Berger S, Martens UM. Olaparib. Recent Results Cancer Res. 
2018;211:217–33.  
161.  Asher G, Reinke H, Altmeyer M, Gutierrez-Arcelus M, Hottiger MO, Schibler U. 
Poly(ADP-ribose) polymerase 1 participates in the phase entrainment of circadian 
clocks to feeding. Cell [Internet]. 2010 Sep 17 [cited 2014 Sep 4];142(6):943–53. 
Available from: http://www.ncbi.nlm.nih.gov/pubmed/20832105 
162.  Takahashi HJS. Transcriptional architecture of the mammalian circadian clock. Nat 
Rev Genet. 2017;18(3):164–79.  
163.  Kim JY, Kwak PB, Weitz CJ. Specificity in Circadian Clock Feedback from Targeted 
Reconstitution of the NuRD Corepressor. Mol Cell [Internet]. 2014;56(6):738–48. 





164.  Senderowicz AM. Flavopiridol: the first cyclin-dependent kinase inhibitor in human 
clinical trials. Invest New Drugs. 1999;17(3):313–20141.  
165.  Rahman Z, Bazaz MR, Devabattula G, Khan MA, Godugu C. Targeting H3K9 
methyltransferase G9a and its related molecule GLP as a potential therapeutic strategy 
for cancer. J Biochem Mol Toxicol. 2020;(October):1–11.  
166.  Seidman SB. Network structure and minimum degree. Soc Networks. 1983;5(3):269–
87.  
167.  Luo Y, He H, Duan M, Huang H, Hu Z, Wang H. Dynamic Functional Connectivity 
Strength Within Different Frequency- Band in Schizophrenia. Front Psychiatry. 
2020;10(February):1–13.  
168.  Braccioli L, De Wit E. CTCF: A Swiss-army knife for genome organization and 
transcription regulation. Essays Biochem. 2019;63(1):157–65.  
169.  Tian W, Han X, Yan M, Xu Y, Duggineni S, Lin N, et al. Structure-based discovery of 
a novel inhibitor targeting the β-catenin/Tcf4 interaction. Biochemistry. 
2012;51(2):724–31.  
170.  Hsu PD, Lander ES, Zhang F. Development and Applications of CRISPR-Cas9 for 
Genome Engineering. Cell. 2014;157(6):1262–78.  
171.  Reddy KL, Feinberg AP. Higher order chromatin organization in cancer. Semin 
Cancer Biol [Internet]. 2013;23(2):109–15. Available from: 
http://dx.doi.org/10.1016/j.semcancer.2012.12.001 
172.  Buchwalter A, Kaneshiro JM, Hetzer MW. Coaching from the sidelines: the nuclear 
periphery in genome regulation. Nat Rev Genet [Internet]. 2019;20(1):39–50. 
Available from: http://dx.doi.org/10.1038/s41576-018-0063-5 
173.  Thanisch K, Song C, Engelkamp D, Koch J, Wang A, Hallberg E, et al. Nuclear 
envelope localization of LEMD2 is developmentally dynamic and lamin A / C 
dependent yet insu ffi cient for heterochromatin tethering. Differentiation. 
2017;94(December 2016):58–70.  
174.  Göndör A, Ohlsson R. Replication timing and epigenetic reprogramming of gene 
expression: a two-way relationship? Nat Rev Genet [Internet]. 2009 Apr;10(4):269–
76. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19274048 
175.  Cremer T, Kreth G, Koester H, Fink RHA, Heintzmann R, Cremer M, et al. 
Chromosome territories, interchromatin domain compartment, and nuclear matrix: An 
integrated view of the functional nuclear architecture. Crit Rev Eukaryot Gene Expr. 
2000;10(2):179–212.  
176.  Reddy KL, Zullo JM, Bertolino E, Singh H. Transcriptional repression mediated by 
repositioning of genes to the nuclear lamina. Nature. 2008;452(7184):243–7.  
177.  Harr JC, Luperchio TR, Wong X, Cohen E, Wheelan SJ, Reddy KL. Directed targeting 
of chromatin to the nuclear lamina is mediated by chromatin state and A-type lamins. J 
Cell Biol. 2015;208(1):33–52.  






179.  van Steensel B, Belmont AS. Lamina-associated domains: links with chromosome 
architecture, heterochromatin and gene repression. Cell. 2017;169(5):780–91.  
180.  Hoelz DHL and A. The Structure of the Nuclear Pore Complex (An Update) Daniel. 
Physiol Behav. 2017;176(3):139–48.  
181.  Becker KG, Barnes KC, Bright TJ, Wang A. The Genetic Association Database. Nat 
Genet. 2004;36(5):431–2.  
182.  Rao SSP, Huang SC, Glenn St Hilaire B, Engreitz JM, Perez EM, Kieffer-Kwon KR, 
et al. Cohesin Loss Eliminates All Loop Domains. Cell [Internet]. 2017;171(2):305-
320.e24. Available from: https://doi.org/10.1016/j.cell.2017.09.026 
183.  Rego A, Sinclair PB, Tao W, Kireev I, Belmont AS. The facultative heterochromatin 
of the inactive X chromosome has a distinctive condensed ultrastructure. J Cell Sci. 
2008;121(7):1119–27.  
184.  Lottersberger F, Karssemeijer RA, Dimitrova N, De Lange T. 53BP1 and the LINC 
Complex Promote Microtubule-Dependent DSB Mobility and DNA Repair. Cell 
[Internet]. 2015;163(4):880–93. Available from: 
http://dx.doi.org/10.1016/j.cell.2015.09.057 
185.  Xie X, Almuzzaini B, Drou N, Kremb S, Yousif A, Östlund Farrants A-K, et al. b -
Actin – dependent global chromatin organization and gene expression programs 
control cellular identity. FASEB J. 2018;Mar;32((3)):1296–314.  
186.  Hoyle NP, Seinkmane E, Putker M, Feeney KA, Toke P, Chesham JE, et al. Circadian 
actin dynamics drive rhythmic fibroblast mobilisation during wound healing. Sci 
Transl Med. 2018;9(415).  
187.  Rudra S, Skibbens R V. Cohesin codes - Interpreting chromatin architecture and the 
many facets of cohesin function. Vol. 126, Journal of Cell Science. 2013. p. 31–41.  
188.  Ball AR, Chen YY, Yokomori K. Mechanisms of cohesin-mediated gene regulation 
and lessons learned from cohesinopathies. Vol. 1839, Biochimica et Biophysica Acta - 
Gene Regulatory Mechanisms. 2014. p. 191–202.  
189.  Tanuma S ichi, Shibui Y, Oyama T, Uchiumi F, Abe H. Targeting poly(ADP-ribose) 
glycohydrolase to draw apoptosis codes in cancer. Biochem Pharmacol [Internet]. 
2019;167(April):163–72. Available from: https://doi.org/10.1016/j.bcp.2019.06.004 
190.  Shiao Li Oei, Ziegler M. ATP for the DNA ligation step in base excision repair is 
generated from poly(ADP-ribose). J Biol Chem. 2000;275(30):23234–9.  
191.  Anania C, Lupiáñez DG. Order and disorder: Abnormal 3D chromatin organization in 
human disease. Brief Funct Genomics. 2020;19(2):128–38.  
192.  Moore JM, Rabaia NA, Smith LE, Fagerlie S, Gurley K, Loukinov D, et al. Loss of 
maternal CTCF is associated with peri-implantation lethality of CtCf null embryos. 
PLoS One. 2012;7(4).  





haploinsufficiency destabilizes DNA methylation and predisposes to cancer. Cell Rep 
[Internet]. 2014;7(4):1020–9. Available from: 
http://dx.doi.org/10.1016/j.celrep.2014.04.004 
194.  Flavahan WA, Drier Y, Liau BB, Gillespie SM, Venteicher AS, Stemmer-
Rachamimov AO, et al. Insulator dysfunction and oncogene activation in IDH mutant 
gliomas. Nature. 2016;529(7584):110–4.  
195.  Filippova GN, Ulmer JE, Moore JM, Ward MD, Hu YJ, Neiman PE, et al. Tumor-
associated zinc finger mutations in the CTCF transcription factor selectively alter its 
DNA-binding specificity. Cancer Res. 2002;62(1):48–52.  
 
